1
|
Tavernier P, van de Bildt M, Kuiken T, Van Den Berge K, De Cock H, Terryn S, Van der Wijden B, Beck O. A Canine Distemper Outbreak in Urban Red Foxes (Vulpes vulpes), in Brussels, Belgium, 2020. J Wildl Dis 2024:500798. [PMID: 38754866 DOI: 10.7589/jwd-d-23-00157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Accepted: 04/02/2024] [Indexed: 05/18/2024]
Abstract
Canine distemper has been observed infrequently in Belgian wildlife, mainly stone martens (Martes foina) and red foxes (Vulpes vulpes). This report describes an outbreak in the Brussels urban red fox population, characterized by its high density. The identified virus matched those within a cluster of viruses found previously in red foxes in Germany. Different canine distemper virus (CDV) strains, found in Belgian wild carnivores, share relationships with viruses found farther east. This and other reports indicate an endemic distribution of CDV in wild carnivores in Europe whereby the complex interplay of population density, group immunity, and infection of metapopulations determines the pattern of spatiotemporally alternating outbreaks.
Collapse
Affiliation(s)
| | - Marco van de Bildt
- Erasmus MC, PO Box 2040, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands
| | - Thijs Kuiken
- Erasmus MC, PO Box 2040, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands
| | - Koen Van Den Berge
- Research Institute for Nature and Forest (INBO), Gaverstraat 4, 9500 Geraardsbergen, Belgium
| | - Hilde De Cock
- Medvet, Emiel Vloorsstraat 9, 2020 Antwerpen, Belgium
| | - Sanne Terryn
- Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium
| | | | - Olivier Beck
- Brussels Environment, Havenlaan 86C/3000, 1000 Brussels, Belgium
| |
Collapse
|
2
|
Zhang J, Rissmann M, Kuiken T, Haagmans BL. Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses. Annu Rev Pathol 2024; 19:423-451. [PMID: 37832946 DOI: 10.1146/annurev-pathol-052620-121224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/15/2023]
Abstract
Over the last two decades the world has witnessed the global spread of two genetically related highly pathogenic coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2. However, the impact of these outbreaks differed significantly with respect to the hospitalizations and fatalities seen worldwide. While many studies have been performed recently on SARS-CoV-2, a comparative pathogenesis analysis with SARS-CoV may further provide critical insights into the mechanisms of disease that drive coronavirus-induced respiratory disease. In this review, we comprehensively describe clinical and experimental observations related to transmission and pathogenesis of SARS-CoV-2 in comparison with SARS-CoV, focusing on human, animal, and in vitro studies. By deciphering the similarities and disparities of SARS-CoV and SARS-CoV-2, in terms of transmission and pathogenesis mechanisms, we offer insights into the divergent characteristics of these two viruses. This information may also be relevant to assessing potential novel introductions of genetically related highly pathogenic coronaviruses.
Collapse
Affiliation(s)
- Jingshu Zhang
- Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands;
| | - Melanie Rissmann
- Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands;
| | - Thijs Kuiken
- Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands;
| | - Bart L Haagmans
- Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands;
| |
Collapse
|
3
|
Caliendo V, Kleyheeg E, Beerens N, Camphuysen KCJ, Cazemier R, Elbers ARW, Fouchier RAM, Kelder L, Kuiken T, Leopold M, Slaterus R, Spierenburg MAH, van der Jeugd H, Verdaat H, Rijks JM. Effect of 2020-21 and 2021-22 Highly Pathogenic Avian Influenza H5 Epidemics on Wild Birds, the Netherlands. Emerg Infect Dis 2024; 30:50-57. [PMID: 38040665 PMCID: PMC10756359 DOI: 10.3201/eid3001.230970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2023] Open
Abstract
The number of highly pathogenic avian influenza (HPAI) H5-related infections and deaths of wild birds in Europe was high during October 1, 2020-September 30, 2022. To quantify deaths among wild species groups with known susceptibility for HPAI H5 during those epidemics, we collected and recorded mortality data of wild birds in the Netherlands. HPAI virus infection was reported in 51 bird species. The species with the highest numbers of reported dead and infected birds varied per epidemic year; in 2020-21, they were within the Anatidae family, in particular barnacle geese (Branta leucopsis) and in 2021-22, they were within the sea bird group, particularly Sandwich terns (Thalasseus sandvicensis) and northern gannet (Morus bassanus). Because of the difficulty of anticipating and modeling the future trends of HPAI among wild birds, we recommend monitoring live and dead wild birds as a tool for surveillance of the changing dynamics of HPAI.
Collapse
|
4
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Mirinavičiūtė G, Niqueux É, Ståhl K, Staubach C, Terregino C, Willgert K, Baldinelli F, Chuzhakina K, Delacourt R, Georganas A, Georgiev M, Kohnle L. Avian influenza overview September-December 2023. EFSA J 2023; 21:e8539. [PMID: 38116102 PMCID: PMC10730024 DOI: 10.2903/j.efsa.2023.8539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2023] Open
Abstract
Between 2 September and 1 December 2023, highly pathogenic avian influenza (HPAI) A(H5) outbreaks were reported in domestic (88) and wild (175) birds across 23 countries in Europe. Compared to previous years, the increase in the number of HPAI virus detections in waterfowl has been delayed, possibly due to a later start of the autumn migration of several wild bird species. Common cranes were the most frequently affected species during this reporting period with mortality events being described in several European countries. Most HPAI outbreaks reported in poultry were primary outbreaks following the introduction of the virus by wild birds, with the exception of Hungary, where two clusters involving secondary spread occurred. HPAI viruses identified in Europe belonged to eleven different genotypes, seven of which were new. With regard to mammals, the serological survey conducted in all fur farms in Finland revealed 29 additional serologically positive farms during this reporting period. Wild mammals continued to be affected mostly in the Americas, from where further spread into wild birds and mammals in the Antarctic region was described for the first time. Since the last report and as of 1 December 2023, three fatal and one severe human A(H5N1) infection with clade 2.3.2.1c viruses have been reported by Cambodia, and one A(H9N2) infection was reported from China. No human infections related to the avian influenza detections in animals in fur farms in Finland have been reported, and human infections with avian influenza remain a rare event. The risk of infection with currently circulating avian H5 influenza viruses of clade 2.3.4.4b in Europe remains low for the general population in the EU/EEA. The risk of infection remains low to moderate for occupationally or otherwise exposed people to infected birds or mammals (wild or domesticated); this assessment covers different situations that depend on the level of exposure.
Collapse
|
5
|
Jaramillo Ortiz L, Begeman L, Schillemans M, Kuiken T, de Boer WF. Presence of coronaviruses in the common pipistrelle (P. pipistrellus) and Nathusius´ pipistrelle (P. nathusii) in relation to landscape composition. PLoS One 2023; 18:e0293649. [PMID: 38019737 PMCID: PMC10686486 DOI: 10.1371/journal.pone.0293649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 10/17/2023] [Indexed: 12/01/2023] Open
Abstract
Changes in land use can modify habitat and roosting behaviour of bats, and therefore the transmission dynamics of viruses. Within bat roosts the density and contact rate among individuals increase and may facilitate the transmission of bat coronaviruses (CoVs). Landscape components supporting larger bat populations may thus lead to higher CoVs prevalence, as the number of roosts and/or roost size are likely to be higher. Hence, relationships between landscape composition and the presence of CoVs are expected to exist. To increase our understanding of the spread and shedding of coronaviruses in bat populations we studied the relationships between landscape composition and CoVs prevalence in the species Pipistrellus pipistrellus and Pipistrellus nathusii. Faecal samples were collected across The Netherlands, and were screened to detect the presence of CoV RNA. Coordinates were recorded for all faecal samples, so that landscape attributes could be quantified. Using a backward selection procedure on the basis of AIC, the landscape variables that best explained the presence of CoVs were selected in the final model. Results suggested that relationships between landscape composition and CoVs were likely associated with optimal foraging opportunities in both species, e.g. nearby water in P. nathusii or in areas with more grassland situated far away from forests for P. pipistrellus. Surprisingly, we found no positive association between built-up cover (where roosts are frequently found) and the presence of bat-CoVs for both species. We also show that samples collected from large bat roosts, such as maternity colonies, substantially increased the probability of finding CoVs in P. pipistrellus. Interestingly, while maternity colonies of P. nathusii are rarely present in The Netherlands, CoVs prevalence was similar in both species, suggesting that other mechanisms besides roost size, participate in the transmission of bat-CoVs. We encourage further studies to quantify bat roosts and colony networks over the different landscape compositions to better understand the ecological mechanisms involved in the transmission of bat-CoVs.
Collapse
Affiliation(s)
- Laura Jaramillo Ortiz
- Wildlife Ecology and Conservation Group, Wageningen University and Research, Wageningen, The Netherlands
| | - Lineke Begeman
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | | | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Willem Frederik de Boer
- Wildlife Ecology and Conservation Group, Wageningen University and Research, Wageningen, The Netherlands
| |
Collapse
|
6
|
Veldhuis Kroeze EJB, van Elk CE, van de Bildt MWG, van Run PRWA, Foster G, Abou-Chakra N, Hare RK, Kuiken T. Infection with Pythium flevoense in a harbour porpoise (Phocoena phocoena) as a novel cause of dermatitis in marine mammals. Vet Res 2023; 54:102. [PMID: 37919808 PMCID: PMC10623814 DOI: 10.1186/s13567-023-01226-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2023] [Accepted: 10/02/2023] [Indexed: 11/04/2023] Open
Abstract
The oomycete Pythium flevoense was diagnosed as the cause of dermatitis in a young adult female harbour porpoise (Phocoena phocoena) that had been trapped in a pound net in a temperate saltwater environment. Disease from Pythium sp. infection-pythiosis-is infrequently diagnosed in humans, horses, dogs, cattle, and few other mammalian species. Pythiosis is typically associated with exposure to tropical or subtropical freshwater conditions, and typically caused by Pythium insidiosum. However, until now, pythiosis has been reported in neither marine mammals nor temperate saltwater conditions, and P. flevoense is not known as a cause of pythiosis in mammals. This porpoise developed generalised dermatitis despite treatment and euthanasia was necessary. Histopathological evaluation revealed a chronic active erosive dermatitis, with intralesional hyphae morphologically consistent with a Pythium sp. PCR analysis and sequencing of affected skin matched Pythium flevoense with a 100% similarity to the reference strain. Additional diagnostics excluded other pathogens. Based on this case report, P. flevoense needs to be considered as a mammalian pathogen. Furthermore, harbour porpoises and possibly other marine mammals may be at risk of infection with P. flevoense, and pythiosis should be included in the differential diagnosis of dermatitis in marine mammals.
Collapse
Affiliation(s)
| | - Cornelis E van Elk
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Marco W G van de Bildt
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Peter R W A van Run
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | | | - Nissrine Abou-Chakra
- Unit for Mycology, Department of Bacteria Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
| | - Rasmus Krøger Hare
- Unit for Mycology, Department of Bacteria Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark
| | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands.
| |
Collapse
|
7
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Mirinavičiūtė G, Niqueux É, Staubach C, Terregino C, Baldinelli F, Rusinà A, Kohnle L. Avian influenza overview June-September 2023. EFSA J 2023; 21:e08328. [PMID: 37809353 PMCID: PMC10552073 DOI: 10.2903/j.efsa.2023.8328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/10/2023] Open
Abstract
Between 24 June and 1 September 2023, highly pathogenic avian influenza (HPAI) A(H5) outbreaks were reported in domestic (25) and wild (482) birds across 21 countries in Europe. Most of these outbreaks appeared to be clustered along coastlines with only few HPAI virus detections inland. In poultry, all HPAI outbreaks were primary and sporadic with most of them occurring in the United Kingdom. In wild birds, colony-breeding seabirds continued to be most heavily affected, but an increasing number of HPAI virus detections in waterfowl is expected in the coming weeks. The current epidemic in wild birds has already surpassed the one of the previous epidemiological year in terms of total number of HPAI virus detections. As regards mammals, A(H5N1) virus was identified in 26 fur animal farms in Finland. Affected species included American mink, red and Arctic fox, and common raccoon dog. The most likely source of introduction was contact with gulls. Wild mammals continued to be affected worldwide, mostly red foxes and different seal species. Since the last report and as of 28 September 2023, two A(H5N1) clade 2.3.4.4b virus detections in humans have been reported by the United Kingdom, and three human infections with A(H5N6) and two with A(H9N2) were reported from China, respectively. No human infection related to the avian influenza detections in animals on fur farms in Finland or in cats in Poland have been reported, and human infections with avian influenza remain a rare event. The risk of infection with currently circulating avian H5 influenza viruses of clade 2.3.4.4b in Europe remains low for the general population in the EU/EEA. The risk of infection remains low to moderate for occupationally or otherwise exposed people to infected birds or mammals (wild or domesticated); this assessment covers different situations that depend on the level of exposure.
Collapse
|
8
|
Herfst S, Begeman L, Spronken MI, Poen MJ, Eggink D, de Meulder D, Lexmond P, Bestebroer TM, Koopmans MPG, Kuiken T, Richard M, Fouchier RAM. A Dutch highly pathogenic H5N6 avian influenza virus showed remarkable tropism for extra-respiratory organs and caused severe disease but was not transmissible via air in the ferret model. mSphere 2023; 8:e0020023. [PMID: 37428085 PMCID: PMC10449504 DOI: 10.1128/msphere.00200-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Accepted: 06/01/2023] [Indexed: 07/11/2023] Open
Abstract
Continued circulation of A/H5N1 influenza viruses of the A/goose/Guangdong/1/96 lineage in poultry has resulted in the diversification in multiple genetic and antigenic clades. Since 2009, clade 2.3.4.4 hemagglutinin (HA) containing viruses harboring the internal and neuraminidase (NA) genes of other avian influenza A viruses have been detected. As a result, various HA-NA combinations, such as A/H5N1, A/H5N2, A/H5N3, A/H5N5, A/H5N6, and A/H5N8 have been identified. As of January 2023, 83 humans have been infected with A/H5N6 viruses, thereby posing an apparent risk for public health. Here, as part of a risk assessment, the in vitro and in vivo characterization of A/H5N6 A/black-headed gull/Netherlands/29/2017 is described. This A/H5N6 virus was not transmitted between ferrets via the air but was of unexpectedly high pathogenicity compared to other described A/H5N6 viruses. The virus replicated and caused severe lesions not only in respiratory tissues but also in multiple extra-respiratory tissues, including brain, liver, pancreas, spleen, lymph nodes, and adrenal gland. Sequence analyses demonstrated that the well-known mammalian adaptation substitution D701N was positively selected in almost all ferrets. In the in vitro experiments, no other known viral phenotypic properties associated with mammalian adaptation or increased pathogenicity were identified. The lack of transmission via the air and the absence of mammalian adaptation markers suggest that the public health risk of this virus is low. The high pathogenicity of this virus in ferrets could not be explained by the known mammalian pathogenicity factors and should be further studied. IMPORTANCE Avian influenza A/H5 viruses can cross the species barrier and infect humans. These infections can have a fatal outcome, but fortunately these influenza A/H5 viruses do not spread between humans. However, the extensive circulation and reassortment of A/H5N6 viruses in poultry and wild birds warrant risk assessments of circulating strains. Here an in-depth characterization of the properties of an avian A/H5N6 influenza virus isolated from a black-headed gull in the Netherlands was performed in vitro and in vivo, in ferrets. The virus was not transmissible via the air but caused severe disease and spread to extra-respiratory organs. Apart from the detection in ferrets of a mutation that increased virus replication, no other mammalian adaptation phenotypes were identified. Our results suggest that the risk of this avian A/H5N6 virus for public health is low. The underlying reasons for the high pathogenicity of this virus are unexplained and should be further studied.
Collapse
Affiliation(s)
- Sander Herfst
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Lineke Begeman
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Monique I. Spronken
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Marjolein J. Poen
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Dirk Eggink
- Academic Medical Center Amsterdam, Laboratory of Experimental Virology, Amsterdam, the Netherlands
| | - Dennis de Meulder
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Pascal Lexmond
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Theo M. Bestebroer
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Marion P. G. Koopmans
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Mathilde Richard
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Ron A. M. Fouchier
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands
| |
Collapse
|
9
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Melidou A, Mirinavičiūtė G, Niqueux É, Ståhl K, Staubach C, Terregino C, Baldinelli F, Broglia A, Kohnle L. Avian influenza overview April - June 2023. EFSA J 2023; 21:e08191. [PMID: 37485254 PMCID: PMC10358191 DOI: 10.2903/j.efsa.2023.8191] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/25/2023] Open
Abstract
Between 29 April and 23 June 2023, highly pathogenic avian influenza (HPAI) A(H5N1) virus (clade 2.3.4.4b) outbreaks were reported in domestic (98) and wild (634) birds across 25 countries in Europe. A cluster of outbreaks in mulard ducks for foie gras production was concentrated in Southwest France, whereas the overall A(H5N1) situation in poultry in Europe and worldwide has eased. In wild birds, black-headed gulls and several new seabird species, mostly gulls and terns (e.g. sandwich terns), were heavily affected, with increased mortality being observed in both adults and juveniles after hatching. Compared to the same period last year, dead seabirds have been increasingly found inland and not only along European coastlines. As regards mammals, A(H5N1) virus was identified in 24 domestic cats and one caracal in Poland between 10 and 30 June 2023. Affected animals showed neurological and respiratory signs, sometimes mortality, and were widely scattered across nine voivodeships in the country. All cases are genetically closely related and identified viruses cluster with viruses detected in poultry (since October 2022, but now only sporadic) and wild birds (December 2022-January 2023) in the past. Uncertainties still exist around their possible source of infection, with no feline-to-feline or feline-to-human transmission reported so far. Since 10 May 2023 and as of 4 July 2023, two A(H5N1) clade 2.3.4.4b virus detections in humans were reported from the United Kingdom, and two A(H9N2) and one A(H5N6) human infections in China. In addition, one person infected with A(H3N8) in China has died. The risk of infection with currently circulating avian H5 influenza viruses of clade 2.3.4.4b in Europe remains low for the general population in the EU/EEA, low to moderate for occupationally or otherwise exposed people to infected birds or mammals (wild or domesticated).
Collapse
|
10
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Mirinaviciute G, Niqueux É, Stahl K, Staubach C, Terregino C, Broglia A, Kohnle L, Baldinelli F. Avian influenza overview March - April 2023. EFSA J 2023; 21:e08039. [PMID: 37293570 PMCID: PMC10245295 DOI: 10.2903/j.efsa.2023.8039] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023] Open
Abstract
Between 2 March and 28 April 2023, highly pathogenic avian influenza (HPAI) A(H5Nx) virus, clade 2.3.4.4b, outbreaks were reported in domestic (106) and wild (610) birds across 24 countries in Europe. Poultry outbreaks occurred less frequently compared to the previous reporting period and compared to spring 2022. Most of these outbreaks were classified as primary outbreaks without secondary spread and some of them associated with atypical disease presentation, in particular low mortality. In wild birds, black-headed gulls continued to be heavily affected, while also other threatened wild bird species, such as the peregrine falcon, showed increased mortality. The ongoing epidemic in black-headed gulls, many of which breed inland, may increase the risk for poultry, especially in July-August, when first-year birds disperse from the breeding colonies. HPAI A(H5N1) virus also continued to expand in the Americas, including in mammalian species, and is expected to reach the Antarctic in the near future. HPAI virus infections were detected in six mammal species, particularly in marine mammals and mustelids, for the first time, while the viruses currently circulating in Europe retain a preferential binding for avian-like receptors. Since 13 March 2022 and as of 10 May 2023, two A(H5N1) clade 2.3.4.4b virus detections in humans were reported from China (1), and Chile (1), as well as three A(H9N2) and one A(H3N8) human infections in China. The risk of infection with currently circulating avian H5 influenza viruses of clade 2.3.4.4b in Europe remains low for the general population in the EU/EEA, and low to moderate for occupationally or otherwise exposed people.
Collapse
|
11
|
Mols VC, Lamers MM, Leijten LME, Breugem TI, van de Bildt MWG, van den Doel PB, Lina PHC, Koopmans MPG, Haagmans BL, Kuiken T, Begeman L. Correction for Mols et al., "Intestinal Tropism of a Betacoronavirus ( Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host". J Virol 2023; 97:e0059623. [PMID: 37154754 DOI: 10.1128/jvi.00596-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023] Open
|
12
|
Kuiken T, Fouchier RAM, Koopmans MPG. Being ready for the next influenza pandemic? Lancet Infect Dis 2023; 23:398-399. [PMID: 36898404 DOI: 10.1016/s1473-3099(23)00117-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Accepted: 02/13/2023] [Indexed: 03/09/2023]
Affiliation(s)
- Thijs Kuiken
- Viroscience Department, Erasmus University Medical Centre, Rotterdam 3015 GD, Netherlands
| | - Ron A M Fouchier
- Viroscience Department, Erasmus University Medical Centre, Rotterdam 3015 GD, Netherlands
| | - Marion P G Koopmans
- Viroscience Department, Erasmus University Medical Centre, Rotterdam 3015 GD, Netherlands.
| |
Collapse
|
13
|
Begeman L, van Riel D, Koopmans MPG, Kuiken T. The pathogenesis of zoonotic viral infections: Lessons learned by studying reservoir hosts. Front Microbiol 2023; 14:1151524. [PMID: 37056741 PMCID: PMC10086422 DOI: 10.3389/fmicb.2023.1151524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Accepted: 03/06/2023] [Indexed: 03/30/2023] Open
Abstract
Zoonotic viral infections that cause severe disease or even death in some people may be asymptomatic or mild in reservoir hosts. Comparison of the pathogenesis of these two host categories may potentially explain the difference in disease. However, infections in reservoir hosts are often neglected. Therefore, we compared the pathogenesis of rabies virus, macacine alphaherpesvirus, West Nile virus, Puumala orthohantavirus, monkeypox virus, Lassa mammarenavirus, H5N1 highly pathogenic avian influenza, Marburg virus, Nipah virus, Middle East respiratory syndrome, and simian/human immunodeficiency viruses in both humans and reservoir hosts. We showed that most aspects of the pathogeneses were remarkably similar. The remaining differences lead to the identification of tipping points in the pathogeneses that are important for explaining the disease outcome in severe human cases. Further elucidating these tipping points by studying zoonotic viral infections in their reservoir hosts may teach us how to reduce the severity of zoonotic viral diseases in humans.
Collapse
Affiliation(s)
- Lineke Begeman
- Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands
- *Correspondence: Lineke Begeman,
| | - Debby van Riel
- Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands
| | - Marion P. G. Koopmans
- Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands
- Pandemic and Disaster Preparedness Centre, Rotterdam, Netherlands
| | - Thijs Kuiken
- Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands
| |
Collapse
|
14
|
Siegers JY, Ferreri L, Eggink D, Veldhuis Kroeze EJB, Te Velthuis AJW, van de Bildt M, Leijten L, van Run P, de Meulder D, Bestebroer T, Richard M, Kuiken T, Lowen AC, Herfst S, van Riel D. Evolution of highly pathogenic H5N1 influenza A virus in the central nervous system of ferrets. PLoS Pathog 2023; 19:e1011214. [PMID: 36897923 PMCID: PMC10032531 DOI: 10.1371/journal.ppat.1011214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Revised: 03/22/2023] [Accepted: 02/16/2023] [Indexed: 03/11/2023] Open
Abstract
Central nervous system (CNS) disease is the most common extra-respiratory tract complication of influenza A virus infections in humans. Remarkably, zoonotic highly pathogenic avian influenza (HPAI) H5N1 virus infections are more often associated with CNS disease than infections with seasonal influenza viruses. Evolution of avian influenza viruses has been extensively studied in the context of respiratory infections, but evolutionary processes in CNS infections remain poorly understood. We have previously observed that the ability of HPAI A/Indonesia/5/2005 (H5N1) virus to replicate in and spread throughout the CNS varies widely between individual ferrets. Based on these observations, we sought to understand the impact of entrance into and replication within the CNS on the evolutionary dynamics of virus populations. First, we identified and characterized three substitutions-PB1 E177G and A652T and NP I119M - detected in the CNS of a ferret infected with influenza A/Indonesia/5/2005 (H5N1) virus that developed a severe meningo-encephalitis. We found that some of these substitutions, individually or collectively, resulted in increased polymerase activity in vitro. Nevertheless, in vivo, the virus bearing the CNS-associated mutations retained its capacity to infect the CNS but showed reduced dispersion to other anatomical sites. Analyses of viral diversity in the nasal turbinate and olfactory bulb revealed the lack of a genetic bottleneck acting on virus populations accessing the CNS via this route. Furthermore, virus populations bearing the CNS-associated mutations showed signs of positive selection in the brainstem. These features of dispersion to the CNS are consistent with the action of selective processes, underlining the potential for H5N1 viruses to adapt to the CNS.
Collapse
Affiliation(s)
- Jurre Y Siegers
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | - Lucas Ferreri
- Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America
| | - Dirk Eggink
- Department of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands
| | | | - Aartjan J W Te Velthuis
- Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America
| | | | - Lonneke Leijten
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | - Peter van Run
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | | | - Theo Bestebroer
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | - Mathilde Richard
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | - Anice C Lowen
- Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America
| | - Sander Herfst
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| | - Debby van Riel
- Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
| |
Collapse
|
15
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Mirinaviciute G, Niqueux É, Stahl K, Staubach C, Terregino C, Broglia A, Baldinelli F. Avian influenza overview December 2022 - March 2023. EFSA J 2023; 21:e07917. [PMID: 36949860 PMCID: PMC10025949 DOI: 10.2903/j.efsa.2023.7917] [Citation(s) in RCA: 28] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/24/2023] Open
Abstract
Between 3 December 2022 and 1 March 2023 highly pathogenic avian influenza (HPAI) A(H5N1) virus, clade 2.3.4.4b, was reported in Europe in domestic (522) and wild (1,138) birds over 24 countries. An unexpected number of HPAI virus detections in sea birds were observed, mainly in gull species and particularly in black-headed gulls (large mortality events were observed in France, Belgium, the Netherlands, and Italy). The close genetic relationship among viruses collected from black-headed gulls suggests a southward spread of the virus. Moreover, the genetic analyses indicate that the virus persisted in Europe in residential wild birds during and after the summer months. Although the virus retained a preferential binding for avian-like receptors, several mutations associated to increased zoonotic potential were detected. The risk of HPAI virus infection for poultry due to the virus circulating in black-headed gulls and other gull species might increase during the coming months, as breeding bird colonies move inland with possible overlap with poultry production areas. Worldwide, HPAI A(H5N1) virus continued to spread southward in the Americas, from Mexico to southern Chile. The Peruvian pelican was the most frequently reported infected species with thousands of deaths being reported. The reporting of HPAI A(H5N1) in mammals also continued probably linked to feeding on infected wild birds. In Peru, a mass mortality event of sea lions was observed in January and February 2023. Since October 2022, six A(H5N1) detections in humans were reported from Cambodia (a family cluster with 2 people, clade 2.3.2.1c), China (2, clade 2.3.4.4b), Ecuador (1, clade 2.3.4.4b), and Vietnam (1, unspecified clade), as well as two A(H5N6) human infections from China. The risk of infection with currently circulating avian H5 influenza viruses of clade 2.3.4.4b in Europe is assessed as low for the general population in the EU/EEA, and low to moderate for occupationally or otherwise exposed people.
Collapse
|
16
|
Wismans LV, Lopuhaä B, de Koning W, Moeniralam H, van Oosterhout M, Ambarus C, Hofman FN, Kuiken T, Endeman H, Mustafa DAM, von der Thüsen JH. Increase of mast cells in COVID-19 pneumonia may contribute to pulmonary fibrosis and thrombosis. Histopathology 2023; 82:407-419. [PMID: 36366933 PMCID: PMC9877713 DOI: 10.1111/his.14838] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2022] [Revised: 10/10/2022] [Accepted: 11/05/2022] [Indexed: 11/13/2022]
Abstract
AIMS Lung tissue from COVID-19 patients shares similar histomorphological features with chronic lung allograft disease, also suggesting activation of autoimmune-related pathways in COVID-19. To more clearly understand the underlying spectrum of pathophysiology in COVID-19 pneumonia, we analysed mRNA expression of autoimmune-related genes in post-mortem lung tissue from COVID-19 patients. METHODS AND RESULTS Formalin-fixed, paraffin-embedded lung tissue samples of 18 COVID-19 patients and eight influenza patients were used for targeted gene expression profiling using NanoString technology. Multiplex immunofluorescence for tryptase and chymase was applied for validation. Genes related to mast cells were significantly increased in COVID-19. This finding was strengthened by multiplex immunofluorescence also showing a significant increase of tryptase- and chymase-positive cells in COVID-19. Furthermore, receptors for advanced glycation end-products (RAGE) and pro-platelet basic protein (PPBP) were up-regulated in COVID-19 compared to influenza. Genes associated with Type I interferon signalling showed a significant correlation to detected SARS-CoV2 pathway-related genes. The comparison of lung tissue samples from both groups based on the presence of histomorphological features indicative of acute respiratory distress syndrome did not result in finding any specific gene or pathways. CONCLUSION Two separate means of measuring show a significant increase of mast cells in SARS-CoV-2-infected lung tissue compared to influenza. Additionally, several genes involved in fibrosis and thrombosis, among which are RAGE and PPBP, are up-regulated in COVID-19. As mast cells are able to induce thrombosis and fibrosis, they may play an important role in the pathogenesis of COVID-19.
Collapse
Affiliation(s)
- Leonoor V Wismans
- Present address:
Department of SurgeryErasmus Medical CenterRotterdamthe Netherlands,The Tumor Immuno‐Pathology Laboratory, Department of PathologyJosephine Nefkens Institute, Erasmus Medical CenterRotterdamthe Netherlands
| | - Boaz Lopuhaä
- Present address:
Department of SurgeryErasmus Medical CenterRotterdamthe Netherlands,Department of PathologyJosephine Nefkens Institute, Erasmus Medical CenterRotterdamthe Netherlands
| | - Willem de Koning
- The Tumor Immuno‐Pathology Laboratory, Department of PathologyJosephine Nefkens Institute, Erasmus Medical CenterRotterdamthe Netherlands,Clinical Bioinformatics Unit, Department of PathologyErasmus Medical CenterRotterdamthe Netherlands
| | - Hazra Moeniralam
- Department of Internal Medicine and Intensive CareSt. Antonius HospitalNieuwegeinthe Netherlands
| | | | - Carmen Ambarus
- Department of Pathology DNASt. Antonius HospitalNieuwegeinthe Netherlands
| | - Frederik N Hofman
- Department of Cardiothoracic SurgerySt. Antonius HospitalNieuwegeinthe Netherlands
| | - Thijs Kuiken
- Department of ViroscienceErasmus Medical CenterRotterdamthe Netherlands
| | - Henrik Endeman
- Department of Adult Intensive CareErasmus Medical CenterRotterdamthe Netherlands
| | - Dana A M Mustafa
- The Tumor Immuno‐Pathology Laboratory, Department of PathologyJosephine Nefkens Institute, Erasmus Medical CenterRotterdamthe Netherlands,Department of PathologyJosephine Nefkens Institute, Erasmus Medical CenterRotterdamthe Netherlands
| | - Jan H von der Thüsen
- Department of PathologyJosephine Nefkens Institute, Erasmus Medical CenterRotterdamthe Netherlands
| |
Collapse
|
17
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Aznar I, Guajardo IM, Baldinelli F. Avian influenza overview September - December 2022. EFSA J 2023; 21:e07786. [PMID: 36698491 PMCID: PMC9851911 DOI: 10.2903/j.efsa.2023.7786] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Between October 2021 and September 2022 Europe has suffered the most devastating highly pathogenic avian influenza (HPAI) epidemic with a total of 2,520 outbreaks in poultry, 227 outbreaks in captive birds, and 3,867 HPAI virus detections in wild birds. The unprecedent geographical extent (37 European countries affected) resulted in 50 million birds culled in affected establishments. In the current reporting period, between 10 September and 2 December 2022, 1,163 HPAI virus detections were reported in 27 European countries in poultry (398), captive (151) and wild birds (613). A decrease in HPAI virus detections in colony-breeding seabirds species and an increase in the number of detections in waterfowl has been observed. The continuous circulation of the virus in the wild reservoir has led to the frequent introduction of the virus into poultry populations. It is suspected that waterfowl might be more involved than seabirds in the incursion of HPAI virus into poultry establishments. In the coming months, the increasing infection pressure on poultry establishments might increase the risk of incursions in poultry, with potential further spread, primarily in areas with high poultry densities. The viruses detected since September 2022 (clade 2.3.4.4b) belong to eleven genotypes, three of which have circulated in Europe during the summer months, while eight represent new genotypes. HPAI viruses were also detected in wild and farmed mammal species in Europe and North America, showing genetic markers of adaptation to replication in mammals. Since the last report, two A(H5N1) detections in humans in Spain, one A(H5N1), one A(H5N6) and one A(H9N2) human infection in China as well as one A(H5) infection without NA-type result in Vietnam were reported, respectively. The risk of infection is assessed as low for the general population in the EU/EEA, and low to medium for occupationally exposed people.
Collapse
|
18
|
Rijks JM, Leopold MF, Kühn S, in ‘t Veld R, Schenk F, Brenninkmeijer A, Lilipaly SJ, Ballmann MZ, Kelder L, de Jong JW, Courtens W, Slaterus R, Kleyheeg E, Vreman S, Kik MJ, Gröne A, Fouchier RA, Engelsma M, de Jong MC, Kuiken T, Beerens N. Mass Mortality Caused by Highly Pathogenic Influenza A(H5N1) Virus in Sandwich Terns, the Netherlands, 2022. Emerg Infect Dis 2022; 28:2538-2542. [PMID: 36418000 PMCID: PMC9707584 DOI: 10.3201/eid2812.221292] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/21/2023] Open
Abstract
We collected data on mass mortality in Sandwich terns (Thalasseus sandvicensis) during the 2022 breeding season in the Netherlands. Mortality was associated with at least 2 variants of highly pathogenic avian influenza A(H5N1) virus clade 2.3.4.4b. We report on carcass removal efforts relative to survival in colonies. Mitigation strategies urgently require structured research.
Collapse
Affiliation(s)
| | | | - Susanne Kühn
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Ronald in ‘t Veld
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Fred Schenk
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Allix Brenninkmeijer
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Sander J. Lilipaly
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Mónika Z. Ballmann
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Leon Kelder
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Job W. de Jong
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Wouter Courtens
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Roy Slaterus
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Erik Kleyheeg
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Sandra Vreman
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Marja J.L. Kik
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Andrea Gröne
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Ron A.M. Fouchier
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Marc Engelsma
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Mart C.M. de Jong
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Thijs Kuiken
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| | - Nancy Beerens
- Dutch Wildlife Health Centre, Utrecht University, Utrecht, the Netherlands (J.M. Rijks, M.J.L. Kik, A. Gröne)
- Wageningen Marine Research, Den Helder, the Netherlands (M.F. Leopold, S. Kühn)
- Staatsbosbeheer Zuid-Hollandse Delta, Numansdorp, the Netherlands (R. in ’t Veld)
- Stichting Het Zeeuwse Landschap, Wilhelminadorp, the Netherlands (F. Schenk)
- Province of Groningen, Groningen, the Netherlands (A. Brenninkmeijer)
- Deltamilieu Projecten, Vlissingen, the Netherlands (S.J. Lilipaly, M.Z. Ballmann)
- Staatsbosbeheer Beheereenheid de Kop, Schoorl, the Netherlands (L. Kelder)
- Bureau Waardenburg, Culemborg, the Netherlands (J.W. de Jong)
- Research Institute for Nature and Forest, Brussels, Belgium (W. Courtens)
- Sovon Dutch Centre for Field Ornithology, Nijmegen, the Netherlands (E. Kleyheeg, R. Slaterus)
- Wageningen Bioveterinary Research, Lelystad, the Netherlands (S. Vreman, M. Engelsma,, N. Beerens)
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands (R.A.M. Fouchier, T. Kuiken)
- Wageningen University and Research, Quantitative Veterinary Epidemiology group, Wageningen, the Netherlands (M.C.M. de Jong)
| |
Collapse
|
19
|
Kuiken T, Cromie R. Protect wildlife from livestock diseases. Science 2022; 378:5. [PMID: 36201576 DOI: 10.1126/science.adf0956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
This summer, seabirds in Europe, North America, and Africa suffered unprecedented high mortality as highly pathogenic avian influenza (HPAI) swept through their breeding colonies. Given that the potential for HPAI-which originated in farmed poultry-to affect wild birds has been known for more than a decade, how were these continents caught off guard? Nations must assume responsibility for protecting wildlife from anthropogenic diseases, particularly those originating from ever-increasing livestock populations.
Collapse
Affiliation(s)
- Thijs Kuiken
- Thijs Kuiken is a professor in the Department of Viroscience at Erasmus University Medical Centre, Rotterdam, Netherlands
| | | |
Collapse
|
20
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Guajardo IM, Chuzhakina K, Baldinelli F. Avian influenza overview June - September 2022. EFSA J 2022; 20:e07597. [PMID: 36247870 PMCID: PMC9552036 DOI: 10.2903/j.efsa.2022.7597] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
The 2021-2022 highly pathogenic avian influenza (HPAI) epidemic season is the largest HPAI epidemic so far observed in Europe, with a total of 2,467 outbreaks in poultry, 47.7 million birds culled in the affected establishments, 187 outbreaks in captive birds, and 3,573 HPAI virus detections in wild birds with an unprecedent geographical extent reaching from Svalbard islands to South Portugal and Ukraine, affecting 37 European countries. Between 11 June and 9 September 2022, 788 HPAI virus detections were reported in 16 European countries in poultry (56), captive (22) and wild birds (710). Several colony-breeding seabird species exhibited widespread and massive mortality from HPAI A(H5N1) virus along the northwest coast of Europe. This resulted in an unprecedentedly high level of HPAI virus detections in wild birds between June and August 2022 and represents an ongoing risk of infection for domestic birds. HPAI outbreaks were still observed in poultry from June to September with five-fold more infected premises than observed during the same period in 2021 and mostly distributed along the Atlantic coast. Response options to this new epidemiological situation include the definition and rapid implementation of suitable and sustainable HPAI mitigation strategies such as appropriate biosecurity measures and surveillance strategies for early detection in the different poultry production systems. The viruses currently circulating in Europe belong to clade 2.3.4.4b with seven genotypes, three of which identified for the first time during this time period, being detected during summer. HPAI A(H5) viruses were also detected in wild mammal species in Europe and North America and showed genetic markers of adaptation to replication in mammals. Since the last report, two A(H5N6), two A(H9N2) and one A(H10N3) human infections were reported in China. The risk of infection is assessed as low for the general population in the EU/EEA, and low to medium for occupationally exposed people.
Collapse
|
21
|
Sikkema RS, Begeman L, Janssen R, Wolters WJ, Geurtsvankessel C, de Bruin E, Hakze‐van der Honing RW, Eblé P, van der Poel WHM, van den Brand JMA, Slaterus R, La Haye M, Koopmans MP, Velkers F, Kuiken T. Risks of SARS-CoV-2 transmission between free-ranging animals and captive mink in the Netherlands. Transbound Emerg Dis 2022; 69:3339-3349. [PMID: 35988158 PMCID: PMC9538022 DOI: 10.1111/tbed.14686] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 08/16/2022] [Accepted: 08/18/2022] [Indexed: 02/07/2023]
Abstract
In the Netherlands, 69 of the 126 (55%) mink farms in total became infected with SARS-CoV-2 in 2020. Despite strict biosecurity measures and extensive epidemiological investigations, the main transmission route remained unclear. A better understanding of SARS-CoV-2 transmission between mink farms is of relevance for countries where mink farming is still common practice and can be used as a case study to improve future emerging disease preparedness. We assessed whether SARS-CoV-2 spilled over from mink to free-ranging animals, and whether free-ranging animals may have played a role in farm-to-farm transmission in the Netherlands. The study encompassed farm visits, farm questionnaires, expert workshops and SARS-CoV-2 RNA and antibody testing of samples from target animal species (bats, birds and free-ranging carnivores). In this study, we show that the open housing system of mink allowed access to birds, bats and most free-ranging carnivores, and that direct and indirect contact with mink was likely after entry, especially for free-ranging carnivores and birds. This allowed SARS-CoV-2 exposure to animals entering the mink farm, and subsequent infection or mechanical carriage by the target animal species. Moreover, mink can escape farms in some cases, and two SARS-CoV-2-positive mink were found outside farm premises. No other SARS-CoV-2-RNA-positive free-ranging animals were detected, suggesting there was no abundant circulation in the species tested during the study period. To investigate previous SARS-CoV-2 infections, SARS-CoV-2 antibody detection using lung extracts of carcasses was set up and validated. One tested beech marten did have SARS-CoV-2 antibodies, but the closest SARS-CoV-2-infected mink farm was outside of its home range, making infection at a mink farm unlikely. Knowing that virus exchange between different species and the formation of animal reservoirs affects SARS-CoV-2 evolution, continued vigilance and monitoring of mink farms and surrounding wildlife remains vital.
Collapse
Affiliation(s)
| | | | | | - Wendy J. Wolters
- Division Farm Animal Health, Department Population Health Sciences, Faculty of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands
| | | | - Erwin de Bruin
- Viroscience, ErasmusMCRotterdamThe Netherlands,Division of Pathology, Department of Biomedical Health Sciences, Faculty of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands
| | | | - Phaedra Eblé
- Wageningen Bioveterinary ResearchLelystadThe Netherlands
| | | | - Judith M. A. van den Brand
- Division of Pathology, Department of Biomedical Health Sciences, Faculty of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands,Dutch Wildlife Health CentreUtrecht UniversityThe Netherlands
| | - Roy Slaterus
- Sovon, Dutch Centre for Field OrnithologyNijmegenThe Netherlands
| | | | | | - Francisca Velkers
- Division Farm Animal Health, Department Population Health Sciences, Faculty of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands
| | | |
Collapse
|
22
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Aznar I, Guajardo IM, Baldinelli F. Avian influenza overview March - June 2022. EFSA J 2022; 20:e07415. [PMID: 35949938 PMCID: PMC9356771 DOI: 10.2903/j.efsa.2022.7415] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
The 2021-2022 highly pathogenic avian influenza (HPAI) epidemic season is the largest epidemic so far observed in Europe, with a total of 2,398 outbreaks in poultry, 46 million birds culled in the affected establishments, 168 detections in captive birds, and 2,733 HPAI events in wild birds in 36 European countries. Between 16 March and 10 June 2022, 1,182 HPAI virus detections were reported in 28 EU/EEA countries and United Kingdom in poultry (750), and in wild (410) and captive birds (22). During this reporting period, 86% of the poultry outbreaks were secondary due to between-farm spread of HPAI virus. France accounted for 68% of the overall poultry outbreaks, Hungary for 24% and all other affected countries for less than 2% each. Most detections in wild birds were reported by Germany (158), followed by the Netherlands (98) and the United Kingdom (48). The observed persistence of HPAI (H5) virus in wild birds since the 2020-2021 epidemic wave indicates that it may have become endemic in wild bird populations in Europe, implying that the health risk from HPAI A(H5) for poultry, humans, and wildlife in Europe remains present year-round, with the highest risk in the autumn and winter months. Response options to this new epidemiological situation include the definition and the rapid implementation of suitable and sustainable HPAI mitigation strategies such as appropriate biosecurity measures and surveillance strategies for early detection measures in the different poultry production systems. Medium to long-term strategies for reducing poultry density in high-risk areas should also be considered. The results of the genetic analysis indicate that the viruses currently circulating in Europe belong to clade 2.3.4.4b. HPAI A(H5) viruses were also detected in wild mammal species in Canada, USA and Japan, and showed genetic markers of adaptation to replication in mammals. Since the last report, four A(H5N6), two A(H9N2) and two A(H3N8) human infections were reported in China and one A(H5N1) in USA. The risk of infection is assessed as low for the general population in the EU/EEA, and low to medium for occupationally exposed people.
Collapse
|
23
|
Li T, Cai H, Yao H, Zhou B, Zhang N, van Vlissingen MF, Kuiken T, Han W, GeurtsvanKessel CH, Gong Y, Zhao Y, Shen Q, Qin W, Tian XX, Peng C, Lai Y, Wang Y, Hutter CAJ, Kuo SM, Bao J, Liu C, Wang Y, Richard AS, Raoul H, Lan J, Seeger MA, Cong Y, Rockx B, Wong G, Bi Y, Lavillette D, Li D. Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun 2022; 13:4359. [PMID: 35896553 PMCID: PMC9329378 DOI: 10.1038/s41467-022-32074-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- Tingting Li
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Hongmin Cai
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Hebang Yao
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Bingjie Zhou
- University of CAS, Beijing, China.,CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Ning Zhang
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China
| | - Martje Fentener van Vlissingen
- Erasmus Laboratory Animal Science Center, Erasmus University Medical Center, Rotterdam, Netherlands.,European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
| | - Thijs Kuiken
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.,Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Wenyu Han
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.,University of CAS, Beijing, China
| | - Corine H GeurtsvanKessel
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.,Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Yuhuan Gong
- University of CAS, Beijing, China.,CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China
| | - Yapei Zhao
- University of CAS, Beijing, China.,CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Quan Shen
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China
| | - Wenming Qin
- National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China
| | - Xiao-Xu Tian
- National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China
| | - Chao Peng
- National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China
| | - Yanling Lai
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.,University of CAS, Beijing, China
| | - Yanxing Wang
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Cedric A J Hutter
- Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
| | - Shu-Ming Kuo
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Juan Bao
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Caixuan Liu
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.,University of CAS, Beijing, China
| | - Yifan Wang
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.,University of CAS, Beijing, China
| | - Audrey S Richard
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
| | - Hervé Raoul
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
| | - Jiaming Lan
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Markus A Seeger
- Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
| | - Yao Cong
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Barry Rockx
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France.,Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Gary Wong
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China. .,Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, QC, Canada.
| | - Yuhai Bi
- University of CAS, Beijing, China. .,CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China.
| | - Dimitri Lavillette
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China. .,Pasteurien College, Soochow University, Jiangsu, China.
| | - Dianfan Li
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
| |
Collapse
|
24
|
Rissmann M, Noack D, van Riel D, Schmitz KS, de Vries RD, van Run P, Lamers MM, GeurtsvanKessel CH, Koopmans MPG, Fouchier RAM, Kuiken T, Haagmans BL, Rockx B. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters. Emerg Microbes Infect 2022; 11:1778-1786. [PMID: 35787236 PMCID: PMC9295819 DOI: 10.1080/22221751.2022.2095932] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
AbstractThe Omicron BA.1 (B.1.1.529) SARS-CoV-2 variant is characterized by a high number of mutations in the viral genome, associated with immune-escape and increased viral spread. It remains unclear whether milder COVID-19 disease progression observed after infection with Omicron BA.1 in humans is due to reduced pathogenicity of the virus or due to pre-existing immunity from vaccination or previous infection. Here, we inoculated hamsters with Omicron BA.1 to evaluate pathogenicity and kinetics of viral shedding, compared to Delta (B.1.617.2) and to animals re-challenged with Omicron BA.1 after previous SARS-CoV-2 614G infection. Omicron BA.1 infected animals showed reduced clinical signs, pathological changes, and viral shedding, compared to Delta-infected animals, but still showed gross- and histopathological evidence of pneumonia. Pre-existing immunity reduced viral shedding and protected against pneumonia. Our data indicate that the observed decrease of disease severity is in part due to intrinsic properties of the Omicron BA.1 variant.
Collapse
Affiliation(s)
- Melanie Rissmann
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Danny Noack
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Debby van Riel
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Katharina S Schmitz
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Rory D de Vries
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Peter van Run
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Mart M Lamers
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | | | - Marion P G Koopmans
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Ron A M Fouchier
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Bart L Haagmans
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Barry Rockx
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| |
Collapse
|
25
|
Geiselhardt F, Peters M, Jo WK, Schadenhofer A, Puff C, Baumgärtner W, Kydyrmanov A, Kuiken T, Piewbang C, Techangamsuwan S, Osterhaus ADME, Beineke A, Ludlow M. Development and Validation of a Pan-Genotypic Real-Time Quantitative Reverse Transcription-PCR Assay To Detect Canine Distemper Virus and Phocine Distemper Virus in Domestic Animals and Wildlife. J Clin Microbiol 2022; 60:e0250521. [PMID: 35491822 PMCID: PMC9116185 DOI: 10.1128/jcm.02505-21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Accepted: 04/09/2022] [Indexed: 11/20/2022] Open
Abstract
Canine distemper virus (CDV) is an animal morbillivirus belonging to the family Paramyxoviridae and has caused major epizootics with high mortality levels in susceptible wildlife species. In recent years, the documented genetic diversity of CDV has expanded, with new genotypes identified in India, the Caspian Sea, and North America. However, no quantitative real-time PCR (RT-qPCR) that has been validated for the detection of all genotypes of CDV is currently available. We have therefore established and characterized a pan-genotypic probe-based RT-qPCR assay based on the detection of a conserved region of the phosphoprotein (P) gene of CDV. This assay has been validated using virus strains representative of six genotypes of CDV in different sample types, including frozen tissue, formalin-fixed paraffin-embedded tissue sections, and virus isolates. The primers and probe target sequences were sufficiently conserved to also enable detection of the phocine distemper virus strains responsible for epizootics in harbor seals in the North Sea in 1988 and 2002. Comparison with two recently published RT-qPCR assays for CDV showed that under equivalent conditions the primers and probe set reported in this study were more sensitive in detecting nucleic acids from an Asia-4 genotype, which displays sequence variation in primer and probe binding sites. In summary, this validated new pan-genotypic RT-qPCR assay will facilitate screening of suspected distemper cases caused by novel genotypes for which full genome sequences are unavailable and have utility in detecting multiple CDV strains in geographical regions where multiple genotypes cocirculate in wildlife.
Collapse
Affiliation(s)
- Franziska Geiselhardt
- Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo-RIZ), Hannover, Germany
| | - Martin Peters
- Chemisches und Veterinäruntersuchungsamt Westfalen, Arnsberg, Germany
| | - Wendy K. Jo
- Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo-RIZ), Hannover, Germany
| | - Alina Schadenhofer
- Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo-RIZ), Hannover, Germany
| | - Christina Puff
- Department of Pathology, University of Veterinary Medicine, Hannover, Germany
| | | | - Aidyn Kydyrmanov
- Laboratory of Viral Ecology, Research and Production Center for Microbiology and Virology, Almaty, Kazakhstan
| | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Chutchai Piewbang
- Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
- Animal Virome and Diagnostic Development Research Group, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
| | - Somporn Techangamsuwan
- Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
- Animal Virome and Diagnostic Development Research Group, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
| | - Albert D. M. E. Osterhaus
- Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo-RIZ), Hannover, Germany
| | - Andreas Beineke
- Chemisches und Veterinäruntersuchungsamt Westfalen, Arnsberg, Germany
| | - Martin Ludlow
- Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo-RIZ), Hannover, Germany
| |
Collapse
|
26
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Aznar I, Muñoz Guajardo I, Baldinelli F. Avian influenza overview December 2021 - March 2022. EFSA J 2022; 20:e07289. [PMID: 35386927 PMCID: PMC8978176 DOI: 10.2903/j.efsa.2022.7289] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Between 9 December 2021 and 15 March 2022, 2,653 highly pathogenic avian influenza (HPAI) virus detections were reported in 33 EU/EEA countries and the UK in poultry (1,030), in wild (1,489) and in captive birds (133). The outbreaks in poultry were mainly reported by France (609), where two spatiotemporal clusters have been identified since October 2021, followed by Italy (131), Hungary (73) and Poland (53); those reporting countries accounted together for 12.8 of the 17.5 million birds that were culled in the HPAI affected poultry establishments in this reporting period. The majority of the detections in wild birds were reported by Germany (767), the Netherlands (293), the UK (118) and Denmark (74). HPAI A(H5) was detected in a wide range of host species in wild birds, indicating an increasing and changing risk for virus incursion into poultry farms. The observed persistence and continuous circulation of HPAI viruses in migratory and resident wild birds will continue to pose a risk for the poultry industry in Europe for the coming months. This requires the definition and the rapid implementation of suitable and sustainable HPAI mitigation strategies such as appropriate biosecurity measures, surveillance plans and early detection measures in the different poultry production systems. The results of the genetic analysis indicate that the viruses currently circulating in Europe belong to clade 2.3.4.4b. Some of these viruses were also detected in wild mammal species in the Netherlands, Slovenia, Finland and Ireland showing genetic markers of adaptation to replication in mammals. Since the last report, the UK reported one human infection with A(H5N1), China 17 human infections with A(H5N6), and China and Cambodia 15 infections with A(H9N2) virus. The risk of infection for the general population in the EU/EEA is assessed as low, and for occupationally exposed people, low to medium.
Collapse
|
27
|
de Graaf J, van Nieuwkoop S, de Meulder D, Lexmond P, Kuiken T, Groeneveld D, Fouchier R, van den Hoogen B. Assessment of the virulence for chickens of Newcastle Disease virus with an engineered multi-basic cleavage site in the fusion protein and disrupted V protein gene. Vet Microbiol 2022; 269:109437. [DOI: 10.1016/j.vetmic.2022.109437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Revised: 04/11/2022] [Accepted: 04/13/2022] [Indexed: 10/18/2022]
|
28
|
Caliendo V, Leijten L, van de Bildt M, Germeraad E, Fouchier RAM, Beerens N, Kuiken T. Tropism of Highly Pathogenic Avian Influenza H5 Viruses from the 2020/2021 Epizootic in Wild Ducks and Geese. Viruses 2022; 14:280. [PMID: 35215873 PMCID: PMC8880460 DOI: 10.3390/v14020280] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2021] [Revised: 01/25/2022] [Accepted: 01/28/2022] [Indexed: 01/27/2023] Open
Abstract
Highly pathogenic avian influenza (HPAI) outbreaks have become increasingly frequent in wild bird populations and have caused mass mortality in many wild bird species. The 2020/2021 epizootic was the largest and most deadly ever reported in Europe, and many new bird species tested positive for HPAI virus for the first time. This study investigated the tropism of HPAI virus in wild birds. We tested the pattern of virus attachment of 2020 H5N8 virus to intestinal and respiratory tissues of key bird species; and characterized pathology of naturally infected Eurasian wigeons (Mareca penelope) and barnacle geese (Branta leucopsis). This study determined that 2020 H5N8 virus had a high level of attachment to the intestinal epithelium (enterotropism) of dabbling ducks and geese and retained attachment to airway epithelium (respirotropism). Natural HPAI 2020 H5 virus infection in Eurasian wigeons and barnacle geese also showed a high level of neurotropism, as both species presented with brain lesions that co-localized with virus antigen expression. We concluded that the combination of respirotropism, neurotropism, and possibly enterotropism, contributed to the successful adaptation of 2020/2021 HPAI H5 viruses to wild waterbird populations.
Collapse
Affiliation(s)
- Valentina Caliendo
- Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; (L.L.); (M.v.d.B.); (R.A.M.F.); (T.K.)
| | - Lonneke Leijten
- Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; (L.L.); (M.v.d.B.); (R.A.M.F.); (T.K.)
| | - Marco van de Bildt
- Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; (L.L.); (M.v.d.B.); (R.A.M.F.); (T.K.)
| | - Evelien Germeraad
- Department of Virology, Wageningen Bioveterinary Research, 8221 RA Lelystad, The Netherlands; (E.G.); (N.B.)
| | - Ron A. M. Fouchier
- Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; (L.L.); (M.v.d.B.); (R.A.M.F.); (T.K.)
| | - Nancy Beerens
- Department of Virology, Wageningen Bioveterinary Research, 8221 RA Lelystad, The Netherlands; (E.G.); (N.B.)
| | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; (L.L.); (M.v.d.B.); (R.A.M.F.); (T.K.)
| |
Collapse
|
29
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Aznar I, Muñoz Guajardo I, Baldinelli F. Avian influenza overview May - September 2021. EFSA J 2022; 20:e07122. [PMID: 35079292 PMCID: PMC8777557 DOI: 10.2903/j.efsa.2022.7122] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
The 2020-2021 avian influenza epidemic with a total of 3,777 reported highly pathogenic avian influenza (HPAI) detections and approximately 22,900,000 affected poultry birds in 31 European Countries appears to be one of the largest HPAI epidemics that has ever occurred in Europe. Between 15 May and 15 September 2021, 162 HPAI virus detections were reported in 17 EU/EEA countries and the UK in poultry (51), in wild (91) and captive birds (20). The detections in poultry were mainly reported by Kosovo (20), Poland (17) and Albania (6). HPAI virus was detected during the summer months in resident wild bird populations mainly in northern Europe. The data presented in this report indicates that HPAI virus is still circulating in domestic and wild bird populations in some European countries and that the epidemic is not over yet. Based on these observations, it appears that the persistence of HPAI A(H5) in Europe continues to pose a risk of further virus incursions in domestic bird populations. Furthermore, during summer, HPAI viruses were detected in poultry and several wild bird species in areas in Russia that are linked to key migration areas of wild waterbirds; this is of concern due to the possible introduction and spread of novel virus strains via wild birds migrating to the EU countries during the autumn from the eastern breeding to the overwintering sites. Nineteen different virus genotypes have been identified so far in Europe and Central Asia since July 2020, confirming a high propensity for this virus to undergo reassortment events. Since the last report, 15 human infections due to A(H5N6) HPAI and five human cases due to A(H9N2) low pathogenic avian influenza (LPAI) virus have been reported from China. Some of these cases were caused by a virus with an HA gene closely related to the A(H5) viruses circulating in Europe. The viruses characterised to date retain a preference for avian-type receptors; however, the reports of transmission events of A(H5) viruses to mammals and humans in Russia, as well as the recent A(H5N6) human cases in China may indicate a continuous risk of these viruses adapting to mammals. The risk of infection for the general population in the EU/EEA is assessed as very low, and for occupationally exposed people low, with large uncertainty due to the high diversity of circulating viruses in the bird populations.
Collapse
|
30
|
Li T, Cai H, Zhao Y, Li Y, Lai Y, Yao H, Liu LD, Sun Z, van Vlissingen MF, Kuiken T, GeurtsvanKessel CH, Zhang N, Zhou B, Lu L, Gong Y, Qin W, Mondal M, Duan B, Xu S, Richard AS, Raoul H, Chen J, Xu C, Wu L, Zhou H, Huang Z, Zhang X, Li J, Wang Y, Bi Y, Rockx B, Chen J, Meng F, Lavillette D, Li D. Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody. EMBO Mol Med 2021; 13:e14544. [PMID: 34672091 PMCID: PMC8646660 DOI: 10.15252/emmm.202114544] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Revised: 10/14/2021] [Accepted: 10/18/2021] [Indexed: 12/14/2022] Open
Abstract
An essential step for SARS-CoV-2 infection is the attachment to the host cell receptor by its Spike receptor-binding domain (RBD). Most of the existing RBD-targeting neutralizing antibodies block the receptor-binding motif (RBM), a mutable region with the potential to generate neutralization escape mutants. Here, we isolated and structurally characterized a non-RBM-targeting monoclonal antibody (FD20) from convalescent patients. FD20 engages the RBD at an epitope distal to the RBM with a KD of 5.6 nM, neutralizes SARS-CoV-2 including the current Variants of Concern such as B.1.1.7, B.1.351, P.1, and B.1.617.2 (Delta), displays modest cross-reactivity against SARS-CoV, and reduces viral replication in hamsters. The epitope coincides with a predicted "ideal" vulnerability site with high functional and structural constraints. Mutation of the residues of the conserved epitope variably affects FD20-binding but confers little or no resistance to neutralization. Finally, in vitro mode-of-action characterization and negative-stain electron microscopy suggest a neutralization mechanism by which FD20 destructs the Spike. Our results reveal a conserved vulnerability site in the SARS-CoV-2 Spike for the development of potential antiviral drugs.
Collapse
|
31
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Aznar I, Guajardo IM, Lima E, Baldinelli F. Avian influenza overview February - May 2021. EFSA J 2021; 19:e06951. [PMID: 34925560 PMCID: PMC8647004 DOI: 10.2903/j.efsa.2021.6951] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The 2020-2021 epidemic with a total of 3,555 reported HPAI detections and around 22,400,000 affected poultry birds in 28 European Countries appears to be one of the largest and most devastating HPAI epidemics ever occurred in Europe. Between 24 February and 14 May 2021, 1,672 highly pathogenic avian influenza (HPAI) virus detections were reported in 24 EU/EEA countries and the UK in poultry (n=580), and in wild (n=1,051) and captive birds (n=41). The majority of the detections in poultry were reported by Poland that accounted for 297 outbreaks occurring in a densely populated poultry area over a short period of time, followed by Germany with 168 outbreaks. Germany accounted for 603 detections in wild birds, followed by Denmark and Poland with 167 and 56 detections, respectively. A second peak of HPAI-associated wild bird mortality was observed from February to April 2021 in north-west Europe. The observed longer persistence of HPAI in wild birds compared to previous years may result in a continuation of the risk for juveniles of wild birds and mammals, as well as for virus entry into poultry farms. Therefore, enhanced awareness among farmers to continue applying stringent biosecurity measures and to monitor and report increases in daily mortality and drops in production parameters, are recommended. Sixteen different genotypes were identified to date in Europe and Russia, suggesting a high propensity of these viruses to reassort. The viruses characterized to date retain a preference for avian-type receptors; however, transmission events to mammals and the identification of sporadic mutations of mammal adaptation, indicate ongoing evolution processes and possible increased ability of viruses within this clade to further adapt and transmit to mammals including humans. Since the last report, two human infections due to A(H5N6) HPAI were reported from China and Laos and 10 human cases due to A(H9N2) low pathogenic avian influenza (LPAI) virus identified in China and Cambodia. The risk of infection for the general population in the EU/EEA is assessed as very low and for occupationally exposed people low. People exposed during avian influenza outbreaks should adhere to protection measures, strictly wear personal protective equipment and get tested immediately when developing respiratory symptoms or conjunctivitis within 10 days after exposure.
Collapse
|
32
|
Embregts CW, Verstrepen B, Langermans JA, Böszörményi KP, Sikkema RS, de Vries RD, Hoffmann D, Wernike K, Smit LA, Zhao S, Rockx B, Koopmans MP, Haagmans BL, Kuiken T, GeurtsvanKessel CH. Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test. One Health 2021; 13:100313. [PMID: 34458548 PMCID: PMC8378998 DOI: 10.1016/j.onehlt.2021.100313] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Revised: 08/17/2021] [Accepted: 08/17/2021] [Indexed: 12/23/2022] Open
Abstract
Assays to measure SARS-CoV-2-specific neutralizing antibodies are important to monitor seroprevalence, to study asymptomatic infections and to reveal (intermediate) hosts. A recently developed assay, the surrogate virus-neutralization test (sVNT) is a quick and commercially available alternative to the "gold standard" virus neutralization assay using authentic virus, and does not require processing at BSL-3 level. The assay relies on the inhibition of binding of the receptor binding domain (RBD) on the spike (S) protein to human angiotensin-converting enzyme 2 (hACE2) by antibodies present in sera. As the sVNT does not require species- or isotype-specific conjugates, it can be similarly used for antibody detection in human and animal sera. In this study, we used 298 sera from PCR-confirmed COVID-19 patients and 151 sera from patients confirmed with other coronavirus or other (respiratory) infections, to evaluate the performance of the sVNT. To analyze the use of the assay in a One Health setting, we studied the presence of RBD-binding antibodies in 154 sera from nine animal species (cynomolgus and rhesus macaques, ferrets, rabbits, hamsters, cats, cattle, mink and dromedary camels). The sVNT showed a moderate to high sensitivity and a high specificity using sera from confirmed COVID-19 patients (91.3% and 100%, respectively) and animal sera (93.9% and 100%), however it lacked sensitivity to detect low titers. Significant correlations were found between the sVNT outcomes and PRNT50 and the Wantai total Ig and IgM ELISAs. While species-specific validation will be essential, our results show that the sVNT holds promise in detecting RBD-binding antibodies in multiple species.
Collapse
Affiliation(s)
| | - Babs Verstrepen
- Biomedical Primate Research Centre, Rijswijk, the Netherlands
| | - Jan A.M. Langermans
- Biomedical Primate Research Centre, Rijswijk, the Netherlands
- Department Population Health Sciences, Division Animals in Science and Society, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
| | | | - Reina S. Sikkema
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Rory D. de Vries
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Donata Hoffmann
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, Insel Riems, Germany
| | - Kerstin Wernike
- Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, Insel Riems, Germany
| | - Lidwien A.M. Smit
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Shan Zhao
- Department of Biomolecular Health Sciences, Virology Division, Faculty of Veterinary Medicine, Utrecht University, the Netherlands
| | - Barry Rockx
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | | | - Bart L. Haagmans
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | | |
Collapse
|
33
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Aznar I, Muñoz Guajardo I, Baldinelli F. Avian influenza overview September - December 2021. EFSA J 2021; 19:e07108. [PMID: 34987626 PMCID: PMC8698678 DOI: 10.2903/j.efsa.2021.7108] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Between 16 September and 8 December 2021, 867 highly pathogenic avian influenza (HPAI) virus detections were reported in 27 EU/EEA countries and the UK in poultry (316), in wild (523) and in captive birds (28). The detections in poultry were mainly reported by Italy (167) followed by Hungary and Poland (35 each). Tha majority of the detections in wild birds were reported by Germany (280), Netherlands (65) and United Kingdom (53). The observed persistence and continuous circulation of HPAI viruses in migratory and resident wild birds will continue to pose a risk for the poultry industry in Europe for the coming months. The frequent occurrence of HPAI A(H5) incursions in commercial farms (including poultry production types considered at low avian influenza risk) raises concern about the capacity of the applied biosecurity measures to prevent virus introduction. Short-term preparedness and medium- and long-term prevention strategies, including revising and reinforcing biosecurity measures, reduction of the density of commercial poultry farms and possible appropriate vaccination strategies, should be implemented. The results of the genetic analysis indicate that the viruses characterised during this reporting period belong to clade 2.3.4.4b. Some of the characterized HPAI A(H5N1) viruses detected in Sweden, Germany, Poland and United Kingdom are related to the viruses which have been circulating in Europe since October 2020; in North, Central, South and East Europe novel reassortant A(H5N1) virus has been introduced starting from October 2021. HPAI A(H5N1) was also detected in wild mammal species in Sweden, Estonia and Finland; some of these strains characterised so far present an adaptive marker that is associated with increased virulence and replication in mammals. Since the last report, 13 human infections due to HPAI A(H5N6) and two human cases due to LPAI A(H9N2) virus have been reported from China. Some of these A(H5N6) cases were caused by a reassortant virus of clade 2.3.4.4b, which possessed an HA gene closely related to the A(H5) viruses circulating in Europe. The risk of infection for the general population in the EU/EEA is assessed as low, and for occupationally exposed people, low to medium, with large uncertainty due to the high diversity of circulating viruses in the bird populations.
Collapse
|
34
|
Affiliation(s)
- Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Centre, Wytemaweg 80, 3000 CA, Rotterdam, The Netherlands.
| |
Collapse
|
35
|
Li T, Cai H, Yao H, Zhou B, Zhang N, van Vlissingen MF, Kuiken T, Han W, GeurtsvanKessel CH, Gong Y, Zhao Y, Shen Q, Qin W, Tian XX, Peng C, Lai Y, Wang Y, Hutter CAJ, Kuo SM, Bao J, Liu C, Wang Y, Richard AS, Raoul H, Lan J, Seeger MA, Cong Y, Rockx B, Wong G, Bi Y, Lavillette D, Li D. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun 2021; 12:4635. [PMID: 34330908 PMCID: PMC8324831 DOI: 10.1038/s41467-021-24905-z] [Citation(s) in RCA: 53] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 07/15/2021] [Indexed: 01/15/2023] Open
Abstract
SARS-CoV-2, the causative agent of COVID-191, features a receptor-binding domain (RBD) for binding to the host cell ACE2 protein1-6. Neutralizing antibodies that block RBD-ACE2 interaction are candidates for the development of targeted therapeutics7-17. Llama-derived single-domain antibodies (nanobodies, ~15 kDa) offer advantages in bioavailability, amenability, and production and storage owing to their small sizes and high stability. Here, we report the rapid selection of 99 synthetic nanobodies (sybodies) against RBD by in vitro selection using three libraries. The best sybody, MR3 binds to RBD with high affinity (KD = 1.0 nM) and displays high neutralization activity against SARS-CoV-2 pseudoviruses (IC50 = 0.42 μg mL-1). Structural, biochemical, and biological characterization suggests a common neutralizing mechanism, in which the RBD-ACE2 interaction is competitively inhibited by sybodies. Various forms of sybodies with improved potency have been generated by structure-based design, biparatopic construction, and divalent engineering. Two divalent forms of MR3 protect hamsters from clinical signs after live virus challenge and a single dose of the Fc-fusion construct of MR3 reduces viral RNA load by 6 Log10. Our results pave the way for the development of therapeutic nanobodies against COVID-19 and present a strategy for rapid development of targeted medical interventions during an outbreak.
Collapse
Affiliation(s)
- Tingting Li
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Hongmin Cai
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Hebang Yao
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Bingjie Zhou
- University of CAS, Beijing, China
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Ning Zhang
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China
| | - Martje Fentener van Vlissingen
- Erasmus Laboratory Animal Science Center, Erasmus University Medical Center, Rotterdam, Netherlands
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
| | - Thijs Kuiken
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Wenyu Han
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
- University of CAS, Beijing, China
| | - Corine H GeurtsvanKessel
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Yuhuan Gong
- University of CAS, Beijing, China
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China
| | - Yapei Zhao
- University of CAS, Beijing, China
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Quan Shen
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China
| | - Wenming Qin
- National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China
| | - Xiao-Xu Tian
- National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China
| | - Chao Peng
- National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), CAS, Shanghai, China
| | - Yanling Lai
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
- University of CAS, Beijing, China
| | - Yanxing Wang
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Cedric A J Hutter
- Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
| | - Shu-Ming Kuo
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Juan Bao
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Caixuan Liu
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
- University of CAS, Beijing, China
| | - Yifan Wang
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
- University of CAS, Beijing, China
| | - Audrey S Richard
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
| | - Hervé Raoul
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
| | - Jiaming Lan
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China
| | - Markus A Seeger
- Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
| | - Yao Cong
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China
| | - Barry Rockx
- European Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL), Paris, France
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Gary Wong
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China.
- Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, QC, Canada.
| | - Yuhai Bi
- University of CAS, Beijing, China.
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), CAS, Beijing, China.
| | - Dimitri Lavillette
- CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai CAS, Shanghai, China.
- Pasteurien College, Soochow University, Jiangsu, China.
| | - Dianfan Li
- State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
| |
Collapse
|
36
|
Haagmans BL, Noack D, Okba NMA, Li W, Wang C, Bestebroer T, de Vries R, Herfst S, de Meulder D, Verveer E, van Run P, Lamers MM, Rijnders B, Rokx C, van Kuppeveld F, Grosveld F, Drabek D, Geurts van Kessel C, Koopmans M, Bosch BJ, Kuiken T, Rockx B. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model. J Infect Dis 2021; 223:2020-2028. [PMID: 34043806 PMCID: PMC8243397 DOI: 10.1093/infdis/jiab289] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Accepted: 05/25/2021] [Indexed: 01/08/2023] Open
Abstract
Effective clinical intervention strategies for COVID-19 are urgently needed.
Although several clinical trials have evaluated the use of convalescent plasma
containing virus-neutralizing antibodies, the levels of neutralizing antibodies
are usually not assessed and the effectiveness has not been proven. We show that
hamsters treated prophylactically with a 1:2560 titer of human convalescent
plasma or a 1:5260 titer of monoclonal antibody were protected against weight
loss, had a significant reduction of virus replication in the lungs and showed
reduced pneumonia . Interestingly, this protective effect was lost with a titer
of 1:320 of convalescent plasma. These data highlight the importance of
screening plasma donors for high levels of neutralizing antibodies. Our data show that prophylactic administration of high levels of neutralizing
antibody, either monoclonal or from convalescent plasma, prevent severe
SARS-CoV-2 pneumonia in a hamster model, and could be used as an alternative or
complementary to other antiviral treatments for COVID-19.
Collapse
Affiliation(s)
- Bart L Haagmans
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Danny Noack
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Nisreen M A Okba
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Wentao Li
- Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
| | - Chunyan Wang
- Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
| | - Theo Bestebroer
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Rory de Vries
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Sander Herfst
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Dennis de Meulder
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Elwin Verveer
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Peter van Run
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Mart M Lamers
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Bart Rijnders
- Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Casper Rokx
- Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Frank van Kuppeveld
- Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
| | - Frank Grosveld
- Department of Cell Biology, Erasmus Medical Center, Rotterdam, the Netherlands.,Harbour BioMed, Rotterdam, the Netherlands
| | - Dubravka Drabek
- Department of Cell Biology, Erasmus Medical Center, Rotterdam, the Netherlands.,Harbour BioMed, Rotterdam, the Netherlands
| | | | - Marion Koopmans
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Berend Jan Bosch
- Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Barry Rockx
- Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands
| |
Collapse
|
37
|
Schoenmakers S, Snijder P, Verdijk RM, Kuiken T, Kamphuis SSM, Koopman LP, Krasemann TB, Rousian M, Broekhuizen M, Steegers EAP, Koopmans MPG, Fraaij PLA, Reiss IKM. Severe Acute Respiratory Syndrome Coronavirus 2 Placental Infection and Inflammation Leading to Fetal Distress and Neonatal Multi-Organ Failure in an Asymptomatic Woman. J Pediatric Infect Dis Soc 2021; 10:556-561. [PMID: 33367801 PMCID: PMC7798999 DOI: 10.1093/jpids/piaa153] [Citation(s) in RCA: 47] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Accepted: 11/23/2020] [Indexed: 12/21/2022]
Abstract
BACKGROUND In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is not considered to be an increased risk for severe maternal outcomes but has been associated with an increased risk for fetal distress. Maternal-fetal transmission of SARS-CoV-2 was initially deemed uncertain; however, recently a few cases of vertical transmission have been reported. The intrauterine mechanisms, besides direct vertical transmission, leading to the perinatal adverse outcomes are not well understood. METHODS Multiple maternal, placental, and neonatal swabs were collected for the detection of SARS-CoV-2 using real-time quantitative polymerase chain reaction (RT-qPCR). Serology of immunoglobulins against SARS-CoV-2 was tested in maternal, umbilical cord, and neonatal blood. Placental examination included immunohistochemical investigation against SARS-CoV-2 antigen expression, with SARS-CoV-2 ribonucleic acid (RNA) in situ hybridization and transmission electron microscopy. RESULTS RT-qPCRs of the oropharynx, maternal blood, vagina, placenta, and urine were all positive over a period of 6 days, while breast milk, feces, and all neonatal samples tested negative. Placental findings showed the presence of SARS-CoV-2 particles with generalized inflammation characterized by histiocytic intervillositis with diffuse perivillous fibrin depositions with damage to the syncytiotrophoblasts. CONCLUSIONS Placental infection by SARS-CoV-2 leads to fibrin depositions hampering fetal-maternal gas exchange with resulting fetal distress necessitating a premature emergency cesarean section. Postpartum, the neonate showed a fetal or pediatric inflammatory multisystem-like syndrome with coronary artery ectasia temporarily associated with SARS-CoV-2 for which admittance and care on the neonatal intensive care unit (NICU) were required, despite being negative for SARS-CoV-2. This highlights the need for awareness of adverse fetal and neonatal outcomes during the current coronavirus disease 2019 pandemic, especially considering that the majority of pregnant women appear asymptomatic.
Collapse
Affiliation(s)
- Sam Schoenmakers
- Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Pauline Snijder
- Department of Neonatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Robert M Verdijk
- Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Sylvia S M Kamphuis
- Department of Pediatric Infectiology, Immunology and Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Laurens P Koopman
- Department of Pediatric Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Thomas B Krasemann
- Department of Pediatric Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Melek Rousian
- Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Michelle Broekhuizen
- Department of Neonatology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Department of Pharmacology and Vascular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Eric A P Steegers
- Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Marion P G Koopmans
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Pieter L A Fraaij
- Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands
- Department of Pediatric Infectiology, Immunology and Rheumatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Irwin K M Reiss
- Department of Neonatology, Erasmus University Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
38
|
Schnitzler JG, Das K, Wohlsein P, Kuiken T, Ludwig A, Lieckfeldt D, Phan C, Phay S, Siebert U. The Irrawaddy dolphin, Orcaella brevirostris from the Mekong river Cambodia: Preliminary health and toxicological investigations. Aquat Toxicol 2021; 234:105812. [PMID: 33799112 DOI: 10.1016/j.aquatox.2021.105812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 03/09/2021] [Accepted: 03/16/2021] [Indexed: 06/12/2023]
Abstract
The subpopulation of the Irrawaddy dolphin (Orcaella brevirostris) living in the Mekong River, Cambodia, is considered to be critically endangered. The aim of the investigation was to gain information about the genetic variation, health status and exposure to toxic compounds of these dolphins. Tissue samples from 27 Irrawaddy river dolphins found dead along the Mekong River between 2004 and 2009 were analysed with regards to genetics, pathology and ecotoxicology. Genetic maternal lineage detection, based on polymorphisms of the mitochondrial d-loop sequences, was performed. Data indicate a genetic separation of the Mekong dolphins from both the coastal population and the Mahakam dolphins. Pathological investigations revealed acute moderate multifocal suppurative bronchopneumonia, moderate periportal hepatic lipidosis, moderate diffuse hepatic atrophy and acute severe diffuse suppurative leptomeningitis. Residue levels of organochlorines and polybrominated diphenyl ethers in Irrawaddy dolphins from the Mekong River were lower than the concentrations reported for other cetaceans in the coastal and riverine waters of Asia, except for Dichlorodiphenyltrichloroethane. A high percentage of organic mercury compared to the immuno-toxic methylmercury was observed. Due to numerous confounding factors, it is not possible to relate levels of pollutants to observed morphological lesions. However, it is likely that chemical contaminants do adversely impact on the health of the Irrawaddy dolphins at present, and have also affected previous generations.
Collapse
Affiliation(s)
- Joseph G Schnitzler
- Institute for Terrestrial and Aquatic Wildlife Research, University of Veterinary Medicine Hannover, Werftstr. 6, 25761 Büsum, Germany.
| | - Krishna Das
- Freshwater and Oceanic Sciences Unit of research (FOCUS-Oceanology), University of Liege, Belgium
| | - Peter Wohlsein
- Department of Pathology, University of Veterinary Medicine Hannover, Foundation, Bünteweg 17, 30559 Hannover, Germany
| | - Thijs Kuiken
- Department of Virology, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
| | - Arne Ludwig
- Leibniz-Institut für Zoo- und Wildtierforschung (IZW), Alfred-Kowalke-Straße 17, 10315 Berlin, Germany
| | - Dietmar Lieckfeldt
- Leibniz-Institut für Zoo- und Wildtierforschung (IZW), Alfred-Kowalke-Straße 17, 10315 Berlin, Germany
| | | | | | - Ursula Siebert
- Institute for Terrestrial and Aquatic Wildlife Research, University of Veterinary Medicine Hannover, Werftstr. 6, 25761 Büsum, Germany
| |
Collapse
|
39
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Muñoz Guajardo I, Lima E, Baldinelli F. Avian influenza overview December 2020 - February 2021. EFSA J 2021; 19:e06497. [PMID: 33717356 PMCID: PMC7927793 DOI: 10.2903/j.efsa.2021.6497] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Between 8 December 2020 and 23 February 2021, 1,022 highly pathogenic avian influenza (HPAI) virus detectionswere reported in 25 EU/EEA countries and the UK in poultry (n=592), wild (n=421) and captive birds (n=9).The majority of the detections were reported by Francethat accounted for 442 outbreaks in poultry,mostly located inthe Landes regionandaffecting the foie gras production industry,and six wild bird detections; Germany,who reported 207 detections in wild birds and 50 poultry outbreaks; Denmark,with 63 detections in wild birds and one poultry outbreak; and Poland,with 37 poultry outbreaks and 24 wild bird detections. Due to the continued presence of HPAI A(H5) viruses in wild birds and the environment,there is still a risk of avian influenza incursions with the potential further spread between establishments, primarily in areas with high poultry densities. As the currently circulating HPAI A(H5N8) virus cancause high mortality also in affected duck farms, mortality eventscan be seen as a good indicator of virus presence. However,also subclinical virusspread in this type of poultry production system have been reported.To improve early detection of infection in poultry within the surveillance zone, the clinical inspection of duck establishments should be complemented by encouraging farmers to collect dead birds to be pooled and tested weekly (bucket sampling).Six different genotypes were identified to date in Europe and Russia, suggesting a high propensity of these viruses to undergo multiple reassortment events. To date, no evidence of fixation of known mutations previously described as associated to zoonotic potential has been observed in HPAI viruses currently circulanting in Europe based on the available sequences.Seven cases due to A(H5N8) HPAI virus have been reported from Russia, all were poultry workerswith mild or no symptoms. Five human cases due to A(H5N6) HPAI and 10 cases due to A(H9N2) LPAI viruseshave been reported from China. The risk for the general population as well as travel-related imported human cases is assessed as very lowand the risk forpeople occupationally exposedpeople as low.Any human infections with avian influenza viruses are notifiablewithin 24 hoursthrough the Early Warning and Response System (EWRS) and the International Health Regulations (IHR) notification system.
Collapse
|
40
|
Embregts CWE, Begeman L, Voesenek CJ, Martina BEE, Koopmans MPG, Kuiken T, GeurtsvanKessel CH. Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7. Front Immunol 2021; 12:622516. [PMID: 33679766 PMCID: PMC7933221 DOI: 10.3389/fimmu.2021.622516] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2020] [Accepted: 01/29/2021] [Indexed: 12/15/2022] Open
Abstract
Rabies virus (RABV) is able to reach the central nervous system (CNS) without triggering a strong immune response, using multiple mechanisms to evade and suppress the host immune system. After infection via a bite or scratch from a rabid animal, RABV comes into contact with macrophages, which are the first antigen-presenting cells (APCs) that are recruited to the area and play an essential role in the onset of a specific immune response. It is poorly understood how RABV affects macrophages, and if the interaction contributes to the observed immune suppression. This study was undertaken to characterize the interactions between RABV and human monocyte-derived macrophages (MDMs). We showed that street RABV does not replicate in human MDMs. Using a recombinant trimeric RABV glycoprotein (rRABV-tG) we showed binding to the nicotinic acetylcholine receptor alpha 7 (nAChr α7) on MDMs, and confirmed the specificity using the nAChr α7 antagonist alpha-bungarotoxin (α-BTX). We found that this binding induced the cholinergic anti-inflammatory pathway (CAP), characterized by a significant decrease in tumor necrosis factor α (TNF-α) upon LPS challenge. Using confocal microscopy we found that induction of the CAP is associated with significant cytoplasmic retention of nuclear factor κB (NF-κB). Co-cultures of human MDMs exposed to street RABV and autologous T cells further revealed that the observed suppression of MDMs might affect their function as T cell activators as well, as we found a significant decrease in proliferation of CD8+ T cells and an increased production of the anti-inflammatory cytokine IL-10. Lastly, using flow cytometric analysis we observed a significant increase in expression of the M2-c surface marker CD163, hinting that street RABV might be able to affect macrophage polarization. Taken together, these results show that street RABV is capable of inducing an anti-inflammatory state in human macrophages, possibly affecting T cell functioning.
Collapse
Affiliation(s)
| | - Lineke Begeman
- Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands
| | | | | | | | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands
| | | |
Collapse
|
41
|
Begeman L, Suu-Ire R, Banyard AC, Drosten C, Eggerbauer E, Freuling CM, Gibson L, Goharriz H, Horton DL, Jennings D, Marston DA, Ntiamoa-Baidu Y, Riesle Sbarbaro S, Selden D, Wise EL, Kuiken T, Fooks AR, Müller T, Wood JLN, Cunningham AA. Experimental Lagos bat virus infection in straw-colored fruit bats: A suitable model for bat rabies in a natural reservoir species. PLoS Negl Trop Dis 2020; 14:e0008898. [PMID: 33320860 PMCID: PMC7771871 DOI: 10.1371/journal.pntd.0008898] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 12/29/2020] [Accepted: 10/19/2020] [Indexed: 12/12/2022] Open
Abstract
Rabies is a fatal neurologic disease caused by lyssavirus infection. Bats are important natural reservoir hosts of various lyssaviruses that can be transmitted to people. The epidemiology and pathogenesis of rabies in bats are poorly understood, making it difficult to prevent zoonotic transmission. To further our understanding of lyssavirus pathogenesis in a natural bat host, an experimental model using straw-colored fruit bats (Eidolon helvum) and Lagos bat virus, an endemic lyssavirus in this species, was developed. To determine the lowest viral dose resulting in 100% productive infection, bats in five groups (four bats per group) were inoculated intramuscularly with one of five doses, ranging from 100.1 to 104.1 median tissue culture infectious dose (TCID50). More bats died due to the development of rabies after the middle dose (102.1 TCID50, 4/4 bats) than after lower (101.1, 2/4; 101.1, 2/4) or higher (103.1, 2/4; 104.1, 2/4) doses of virus. In the two highest dose groups, 4/8 bats developed rabies. Of those bats that remained healthy 3/4 bats seroconverted, suggesting that high antigen loads can trigger a strong immune response that abrogates a productive infection. In contrast, in the two lowest dose groups, 3/8 bats developed rabies, 1/8 remained healthy and seroconverted and 4/8 bats remained healthy and did not seroconvert, suggesting these doses are too low to reliably induce infection. The main lesion in all clinically affected bats was meningoencephalitis associated with lyssavirus-positive neurons. Lyssavirus antigen was detected in tongue epithelium (5/11 infected bats) rather than in salivary gland epithelium (0/11), suggesting viral excretion via the tongue. Thus, intramuscular inoculation of 102.1 TCID50 of Lagos bat virus into straw-colored fruit bats is a suitable model for lyssavirus associated bat rabies in a natural reservoir host, and can help with the investigation of lyssavirus infection dynamics in bats.
Collapse
Affiliation(s)
- Lineke Begeman
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
- * E-mail: (LB); (AAC)
| | - Richard Suu-Ire
- School of Veterinary Medicine, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
| | - Ashley C. Banyard
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Christian Drosten
- Institute of Virology, Medical University of Berlin, Berlin, Germany
| | - Elisa Eggerbauer
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
- Thüringer Landesamt für Verbraucherschutz, Bad Langensalza, Thüringen, Germany
| | - Conrad M. Freuling
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | - Louise Gibson
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
| | - Hooman Goharriz
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Daniel L. Horton
- School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom
| | - Daisy Jennings
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Denise A. Marston
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Yaa Ntiamoa-Baidu
- Centre for African Wetlands / Department of Animal Biology and Conservation Science, University of Ghana, Accra, Ghana
| | - Silke Riesle Sbarbaro
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
- University of Cambridge, Cambridge, United Kingdom
| | - David Selden
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Emma L. Wise
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Anthony R. Fooks
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | | | - Andrew A. Cunningham
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
- * E-mail: (LB); (AAC)
| |
Collapse
|
42
|
Abstract
Over the past decade, pandemics caused by pandemic H1N1 (pH1N1) influenza virus in 2009 and severe acute respiratory syndrome virus type 2 (SARS-CoV-2) in 2019 have emerged. Both are high-impact respiratory pathogens originating from animals. Their wide distribution in the human population subsequently results in an increased risk of human-to-animal transmission: reverse zoonosis. Although there have only been rare reports of reverse zoonosis events associated with the ongoing coronavirus disease 2019 (COVID-19) pandemic from SARS-CoV-2 so far, comparison with the pH1N1 influenza pandemic can provide a better understanding of the possible consequences of such events for public and animal health. The results of our review suggest that similar factors contribute to successful crossing of the host species barriers in both pandemics. Specific risk factors include sufficient interaction between infected humans and recipient animals, suitability of the animal host factors for productive virus infection, and suitability of the animal host population for viral persistence. Of particular concern is virus spread to susceptible animal species, in which group housing and contact network structure could potentially result in an alternative virus reservoir, from which reintroduction into humans can take place. Virus exposure in high-density populations could allow sustained transmission in susceptible animal species. Identification of the risk factors and serological surveillance in SARS-CoV-2-susceptible animal species that are group-housed should help reduce the threat from reverse zoonosis of COVID-19.
Collapse
Affiliation(s)
| | - Thijs Kuiken
- Erasmus University Medical Centre, Rotterdam, Netherlands
| |
Collapse
|
43
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Terregino C, Baldinelli F. Avian influenza overview August - December 2020. EFSA J 2020; 18:e06379. [PMID: 33343738 PMCID: PMC7744019 DOI: 10.2903/j.efsa.2020.6379] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Between 15 August and 7 December 2020, 561highly pathogenic avian influenza (HPAI) virus detections were reported in 15EU/EEA countries and UK in wild birds, poultry andcaptive birds, with Germany (n=370), Denmark (n=65), the Netherlands (n=57) being the most affected countries.The majority of the detections have been reported in wild birds(n=510), primarily in barnacle goose, greylag goose, andEurasian wigeon. Raptors have also been detected infected, particularly common buzzard. The majority of the birds had been found dead or moribund,however, there are also reports ofHPAI virus infection in apparently healthy ducks or geese.A total of 43 HPAI outbreaks were notified in poultry;with signs of avian influenza infection being observed in at least 33 outbreaks;the most likely source of infection was indirect contact with wild birds. Three HPAI virus subtypes, A(H5N8) (n=518), A(H5N5) (n=17) and A(H5N1) (n=6),and four different genotypes were identified, suggesting the occurrence of multiple virus introductions into Europe.The reassortant A(H5N1) virus identified in EU/EEA countries has acquired gene segments from low pathogenic viruses and is not related to A(H5N1) viruses of e.g. clade 2.3.2.1c causing human infections outside of Europe. As the autumn migration of wild waterbirds to their wintering areasin Europe continues, and given the expected local movements of these birds, there is still a high risk of introduction andfurther spread ofHPAI A(H5) viruses within Europe.The risk of virus spread from wild birds to poultry is high and Member States should enforce in 'high risk areas' of their territories the measures provided for in Commission Implementing Decision (EU) 2018/1136.Detection of outbreaks in breeder farms in Denmark, the Netherlands and United Kingdom, highlight also the risk of introduction via contaminated materials (bedding/straw) and equipment.Maintaining high and sustainable surveillance and biosecurityparticularly in high-risk areas is of utmost importance. Two human cases due to zoonoticA(H5N1) and A(H9N2) avian influenza virus infection were reportedduring the reporting period. The risk for the general population as well as travel-related imported human cases are assessed as very low.
Collapse
|
44
|
Genzel L, Adan R, Berns A, van den Beucken JJJP, Blokland A, Boddeke EHWGM, Bogers WM, Bontrop R, Bulthuis R, Bousema T, Clevers H, Coenen TCJJ, van Dam AM, Deen PMT, van Dijk KW, Eggen BJL, Elgersma Y, Erdogan I, Englitz B, Fentener van Vlissingen JM, la Fleur S, Fouchier R, Fitzsimons CP, Frieling W, Haagmans B, Heesters BA, Henckens MJAG, Herfst S, Hol E, van den Hove D, de Jonge MI, Jonkers J, Joosten LAB, Kalsbeek A, Kamermans M, Kampinga HH, Kas MJ, Keijer J, Kersten S, Kiliaan AJ, Kooij TWA, Kooijman S, Koopman WJH, Korosi A, Krugers HJ, Kuiken T, Kushner SA, Langermans JAM, Lesscher HMB, Lucassen PJ, Lutgens E, Netea MG, Noldus LPJJ, van der Meer JWM, Meye FJ, Mul JD, van Oers K, Olivier JDA, Pasterkamp RJ, Philippens IHCHM, Prickaerts J, Pollux BJA, Rensen PCN, van Rheenen J, van Rij RP, Ritsma L, Rockx BHG, Roozendaal B, van Schothorst EM, Stittelaar K, Stockhofe N, Swaab DF, de Swart RL, Vanderschuren LJMJ, de Vries TJ, de Vrij F, van Wezel R, Wierenga CJ, Wiesmann M, Willuhn I, de Zeeuw CI, Homberg JR. How the COVID-19 pandemic highlights the necessity of animal research. Curr Biol 2020; 30:4328. [PMID: 33142090 PMCID: PMC7605800 DOI: 10.1016/j.cub.2020.10.033] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
45
|
Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux É, Staubach C, Smietanka K, Terregino C, Van der Stede Y, Aznar I, Baldinelli F. Avian influenza overview - update on 19 November 2020, EU/EEA and the UK. EFSA J 2020; 18:e06341. [PMID: 33281979 PMCID: PMC7684971 DOI: 10.2903/j.efsa.2020.6341] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Since 16 October 2020, outbreaks ofhighly pathogenic avian influenza (HPAI) viruseshavebeen reported inseveral EU/EEAcountries -Belgium, Denmark, France, Germany, Ireland, the Netherlands, and Swedenas well asin the United Kingdom.As of 19 November,12pm, 302 HPAI A(H5) detections have been reported, with the majority of the detections referring to wild birds (n=281), and a few related to outbreaks in poultry (n=18) and captive birds (n=3). Most of the detections in wild birds were in wild waterbirds,being barnacle goose the most affected species (n=110), followed by greylag goose (n=47), Eurasian wigeon (n=32),mallard (n=14), and common buzzard (n=13).ThreeHPAI virus subtypes were identified, A(H5N8), A(H5N5) and A(H5N1), with A(H5N8) being the most reported subtype (n=284). Phylogenetic analysis indicated that the viruses evolved from a single progenitor virus thatwent through multiple reassortment events. Based on the ongoing autumn migration of wild waterbirds to their wintering areas in Europe, there is a continued risk of further introduction of HPAI A(H5) viruses into Europe. Furthermore, given the expected movements of both migratory, and resident wild birds in Europe during winter, there is a high risk of further spread of HPAI A(H5) viruses within Europe. No genetic markers indicating adaptation to mammals have been identified in the viruses analysed so far,andno human infection due to avian influenza viruses detected in the recent outbreakshas been reported. For that reason,the risk to the general population remains very low.However,following the precautionary principle, people should avoid touching sick or dead birds unprotected to minimise any potential risk.
Collapse
|
46
|
Zwart P, Kuiken T, Veldhuis Kroeze EJ, Knotek S, Divers SJ. Nephromegaly due to Disruption of Nephrons in the Green Iguana (Iguana iguana). J Comp Pathol 2020; 181:1-6. [PMID: 33288144 DOI: 10.1016/j.jcpa.2020.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Revised: 07/27/2020] [Accepted: 09/18/2020] [Indexed: 11/19/2022]
Abstract
We describe a fatal kidney disease in green iguanas (Iguana iguana), associated with severe nephromegaly. Affected animals have enlarged kidneys, which fill the pelvic cavity, leading to compression of adjacent organs, obstipation and, ultimately, death. The pathological features of this disease have been poorly described and its aetiology is unknown. We performed detailed gross and histological analyses of 17 green iguanas with a clinical diagnosis of nephromegaly, and compared the results with those of eight healthy controls. Grossly, the kidneys of all 17 individuals were markedly enlarged and the distal colons were distended and overfilled with faecal contents. Histopathological examination revealed that these enlarged kidneys consisted mainly of tubular hyperplasia, resembling poorly developed proximal segments. The nephrogenic zones were either poorly developed or absent. There was a reduction in the density of glomeruli and the distal segments were reduced in number. There was no histological evidence of an aetiology for the nephron disruption and nephromegaly.
Collapse
Affiliation(s)
- Peernel Zwart
- Department of Pathobiology, Faculty of Veterinary Medicine, University of Utrecht, Utrecht, the Netherlands.
| | - Thijs Kuiken
- Erasmus University Medical Center, Rotterdam, the Netherlands
| | | | - Sid Knotek
- Avian and Exotic Animal Clinic, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
| | - Steve J Divers
- Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA
| |
Collapse
|
47
|
Caliendo V, Leijten L, Begeman L, Poen MJ, Fouchier RAM, Beerens N, Kuiken T. Enterotropism of highly pathogenic avian influenza virus H5N8 from the 2016/2017 epidemic in some wild bird species. Vet Res 2020; 51:117. [PMID: 32928280 PMCID: PMC7491185 DOI: 10.1186/s13567-020-00841-6] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Accepted: 09/02/2020] [Indexed: 12/17/2022] Open
Abstract
In 2016/2017, H5N8 highly pathogenic avian influenza (HPAI) virus of the Goose/Guangdong lineage spread from Asia to Europe, causing the biggest and most widespread HPAI epidemic on record in wild and domestic birds in Europe. We hypothesized that the wide dissemination of the 2016 H5N8 virus resulted at least partly from a change in tissue tropism from the respiratory tract, as in older HPAIV viruses, to the intestinal tract, as in low pathogenic avian influenza (LPAI) viruses, allowing more efficient faecal-oral transmission. Therefore, we determined the tissue tropism and associated lesions in wild birds found dead during the 2016 H5N8 epidemic, as well as the pattern of attachment of 2016 H5N8 virus to respiratory and intestinal tissues of four key wild duck species. We found that, out of 39 H5N8-infected wild birds of 12 species, four species expressed virus antigen in both respiratory and intestinal epithelium, one species only in respiratory epithelium, and one species only in intestinal epithelium. Virus antigen expression was association with inflammation and necrosis in multiple tissues. The level of attachment to wild duck intestinal epithelia of 2016 H5N8 virus was comparable to that of LPAI H4N5 virus, and higher than that of 2005 H5N1 virus for two of the four duck species and chicken tested. Overall, these results indicate that 2016 H5N8 may have acquired a similar enterotropism to LPAI viruses, without having lost the respirotropism of older HPAI viruses of the Goose/Guangdong lineage. The increased enterotropism of 2016 H5N8 implies that this virus had an increased chance to persist long term in the wild waterbird reservoir.
Collapse
Affiliation(s)
- Valentina Caliendo
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Lonneke Leijten
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Lineke Begeman
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Marjolein J Poen
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Ron A M Fouchier
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Nancy Beerens
- Department of Virology, Wageningen Bioveterinary Research, Lelystad, The Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
| |
Collapse
|
48
|
Adlhoch C, Fusaro A, Kuiken T, Niqueux É, Staubach C, Terregino C, Muñoz Guajardo I, Baldinelli F. Avian influenza overview May - August 2020. EFSA J 2020; 18:e06270. [PMID: 33281980 PMCID: PMC7525800 DOI: 10.2903/j.efsa.2020.6270] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Between 16 May and 15 August 2020, seven highly pathogenic avian influenza (HPAI) A(H5N8) virus outbreaks were reported in Europe in poultry, with one outbreak reported in Bulgaria(n=1) andsix in Hungary (n=6) and one low pathogenic avian influenza (LPAI) A(H5N3) virus outbreak was reported in poultry in Italy. All six outbreaks detected in Hungary were secondary outbreaks and seem to be the tail end of the HPAI A(H5N8) epidemic that wasobserved in poultry over the winter and spring in central Europe from December 2019 (n=334).Genetic analysis of the HPAI A(H5N8) viruses isolated during this reporting period from Bulgaria and Hungary did not identify any major changes compared tothe viruses collected in the respective countries during the first months of 2020. This suggests a persistence of the virus in the two countries rather than new introductions via infectedwild birds. HPAI A(H5N8) virus has been detected in poultry and wild birds in western Russia within the reporting period, and as of the middle of September also in Kazakhstan. The presence of HPAI virus in western Russiaand in north Kazakhstan,spatially associated with autumnmigration routes of wild waterbirds, is of concern due to the possible spread of the virus via wild birds migrating to the EU.It is highly recommended thatMember States take appropriate measures to promptly detect suspected cases of HPAI, including increasing biosecurity measures. According to past experiences (2005-2006 and 2016-2017 epidemic waves), the northern and eastern European areas might be at higher risk of virus introduction in the coming autumn-winter seasonand should be the key regions where prompt response measures to early detect the virusshould be set up. One human case due to A(H9N2) avian influenza virus infection was reported during the reporting period.
Collapse
|
49
|
Genzel L, Adan R, Berns A, van den Beucken JJJP, Blokland A, Boddeke EHWGM, Bogers WM, Bontrop R, Bulthuis R, Bousema T, Clevers H, Coenen TCJJ, van Dam AM, Deen PMT, van Dijk KW, Eggen BJL, Elgersma Y, Erdogan I, Englitz B, Fentener van Vlissingen JM, la Fleur S, Fouchier R, Fitzsimons CP, Frieling W, Haagmans B, Heesters BA, Henckens MJAG, Herfst S, Hol E, van den Hove D, de Jonge MI, Jonkers J, Joosten LAB, Kalsbeek A, Kamermans M, Kampinga HH, Kas MJ, Keijer JA, Kersten S, Kiliaan AJ, Kooij TWA, Kooijman S, Koopman WJH, Korosi A, Krugers HJ, Kuiken T, Kushner SA, Langermans JAM, Lesscher HMB, Lucassen PJ, Lutgens E, Netea MG, Noldus LPJJ, van der Meer JWM, Meye FJ, Mul JD, van Oers K, Olivier JDA, Pasterkamp RJ, Philippens IHCHM, Prickaerts J, Pollux BJA, Rensen PCN, van Rheenen J, van Rij RP, Ritsma L, Rockx BHG, Roozendaal B, van Schothorst EM, Stittelaar K, Stockhofe N, Swaab DF, de Swart RL, Vanderschuren LJMJ, de Vries TJ, de Vrij F, van Wezel R, Wierenga CJ, Wiesmann M, Willuhn I, de Zeeuw CI, Homberg JR. How the COVID-19 pandemic highlights the necessity of animal research. Curr Biol 2020; 30:R1014-R1018. [PMID: 32961149 PMCID: PMC7416712 DOI: 10.1016/j.cub.2020.08.030] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Recently, a petition was offered to the European Commission calling for an immediate ban on animal testing. Although a Europe-wide moratorium on the use of animals in science is not yet possible, there has been a push by the non-scientific community and politicians for a rapid transition to animal-free innovations. Although there are benefits for both animal welfare and researchers, advances on alternative methods have not progressed enough to be able to replace animal research in the foreseeable future. This trend has led first and foremost to a substantial increase in the administrative burden and hurdles required to make timely advances in research and treatments for human and animal diseases. The current COVID-19 pandemic clearly highlights how much we actually rely on animal research. COVID-19 affects several organs and systems, and the various animal-free alternatives currently available do not come close to this complexity. In this Essay, we therefore argue that the use of animals is essential for the advancement of human and veterinary health.
Collapse
Affiliation(s)
- Lisa Genzel
- Radboud University, 6525 XZ Nijmegen, The Netherlands.
| | - Roger Adan
- University Medical Center, Utrecht Brain Center, Utrecht University, 3584 CG Utrecht, The Netherlands
| | - Anton Berns
- Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
| | | | - Arjan Blokland
- Maastricht University, 6211 LK Maastricht, The Netherlands
| | - Erik H W G M Boddeke
- University of Groningen, 9712 CP Groningen, The Netherlands; University of Groningen, University Medical Center, 9713 GZ Groningen, The Netherlands
| | - Willy M Bogers
- Biomedical Primate Research Centre, 2288 GJ Rijswijk, The Netherlands
| | - Ronald Bontrop
- Biomedical Primate Research Centre, 2288 GJ Rijswijk, The Netherlands
| | - R Bulthuis
- Metris BV, 2132 NG Hoofddorp, The Netherlands
| | - Teun Bousema
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Hans Clevers
- University Medical Center, 3584 CX Utrecht, The Netherlands
| | | | - Anne-Marie van Dam
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands
| | | | - K W van Dijk
- Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
| | - Bart J L Eggen
- University of Groningen, 9712 CP Groningen, The Netherlands; University of Groningen, University Medical Center, 9713 GZ Groningen, The Netherlands
| | - Ype Elgersma
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Izel Erdogan
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | | | | | - Susanne la Fleur
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands; Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
| | - Ron Fouchier
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Carlos P Fitzsimons
- Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
| | | | - Bart Haagmans
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Balthasar A Heesters
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands
| | | | - Sander Herfst
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Elly Hol
- University Medical Center, Utrecht Brain Center, Utrecht University, 3584 CG Utrecht, The Netherlands
| | | | - Marien I de Jonge
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Jos Jonkers
- Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; Oncode Institute, 3521 AL Utrecht, The Netherlands
| | - Leo A B Joosten
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Andries Kalsbeek
- Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
| | - Maarten Kamermans
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands; Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
| | - Harm H Kampinga
- University of Groningen, University Medical Center, 9713 GZ Groningen, The Netherlands
| | - Martien J Kas
- University of Groningen, 9712 CP Groningen, The Netherlands
| | - J Aap Keijer
- Wageningen University, 6700 AH Wageningen, The Netherlands
| | - Sander Kersten
- Wageningen University, 6700 AH Wageningen, The Netherlands
| | - Amanda J Kiliaan
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Taco W A Kooij
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Sander Kooijman
- Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
| | | | - Aniko Korosi
- Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
| | - Harm J Krugers
- Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
| | - Thijs Kuiken
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Steven A Kushner
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Jan A M Langermans
- Biomedical Primate Research Centre, 2288 GJ Rijswijk, The Netherlands; Utrecht University, 3584 CS Utrecht, The Netherlands
| | | | - Paul J Lucassen
- Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
| | - Esther Lutgens
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands
| | - Mihai G Netea
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands; Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany
| | | | | | - Frank J Meye
- University Medical Center, Utrecht Brain Center, Utrecht University, 3584 CG Utrecht, The Netherlands
| | - Joram D Mul
- Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
| | - Kees van Oers
- Wageningen University, 6700 AH Wageningen, The Netherlands; Netherlands Institute of Ecology(NIOO-KNAW), 6700 AB Wageningen, The Netherlands
| | | | - R Jeroen Pasterkamp
- University Medical Center, Utrecht Brain Center, Utrecht University, 3584 CG Utrecht, The Netherlands
| | | | - Jos Prickaerts
- Maastricht University, 6211 LK Maastricht, The Netherlands
| | - B J A Pollux
- Wageningen University, 6700 AH Wageningen, The Netherlands
| | | | | | - Ronald P van Rij
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Laila Ritsma
- Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
| | - Barry H G Rockx
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | - Benno Roozendaal
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | | | - K Stittelaar
- Viroclinics Xplore, 5374 RE Schaijk, The Netherlands
| | - Norbert Stockhofe
- Wageningen University, 6700 AH Wageningen, The Netherlands; Wageningen Bioveterinary Research, 8221 RA Lelystad, The Netherlands
| | - Dick F Swaab
- Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
| | - Rik L de Swart
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | | | - Taco J de Vries
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands
| | - Femke de Vrij
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
| | | | | | | | - Ingo Willuhn
- Amsterdam UMC, location VU University Medical Center, De Boelelaan 1105, 1081 HZ Amsterdam, The Netherlands; Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
| | - Chris I de Zeeuw
- Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands; Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
| | - Judith R Homberg
- Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
| |
Collapse
|
50
|
Rijsbergen LC, Rennick LJ, Laksono BM, van Run PRWA, Kuiken T, Duprex WP, de Swart RL, de Vries RD. In vivo comparison of a laboratory-adapted and clinical-isolate-based recombinant human respiratory syncytial virus. J Gen Virol 2020; 101:1037-1046. [PMID: 32692644 DOI: 10.1099/jgv.0.001468] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Human respiratory syncytial virus (HRSV) is the leading cause of severe respiratory tract disease in infants. Most HRSV infections remain restricted to the upper respiratory tract (URT), but in a small percentage of patients the infection spreads to the lower respiratory tract, resulting in bronchiolitis or pneumonia. We have a limited understanding of HRSV pathogenesis and what factors determine disease severity, partly due to the widespread use of tissue-culture-adapted viruses. Here, we studied early viral dissemination and tropism of HRSV in cotton rats, BALB/cJ mice and C57BL/6 mice. We used a novel recombinant (r) strain based on a subgroup A clinical isolate (A11) expressing EGFP [rHRSVA11EGFP(5)]. A recombinant laboratory-adapted HRSV strain [rHRSVA2EGFP(5)] was used as a direct comparison. Our results show that rHRSVA11EGFP(5) replicated to higher viral titres than laboratory-adapted rHRSVA2EGFP(5) in the URT of cotton rats and mice. HRSV-infected cells were detected as early as 2 days post-inoculation in both species in the nasal septa and lungs. Infection was predominantly present in ciliated epithelial cells in cotton rats and in the olfactory mucosa of mice. In our opinion, this study highlights that the choice of virus strain is important when studying HRSV pathogenesis in vivo and demonstrates that A11 is a representative clinical-based virus. Additionally, we show critical differences in tropism and inflammation when comparing HRSV infection of cotton rats and mice.
Collapse
Affiliation(s)
- Laurine C Rijsbergen
- Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - Linda J Rennick
- Department of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.,Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA
| | - Brigitta M Laksono
- Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - Peter R W A van Run
- Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - Thijs Kuiken
- Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - W Paul Duprex
- Department of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.,Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA
| | - Rik L de Swart
- Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - Rory D de Vries
- Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus MC, Rotterdam, The Netherlands
| |
Collapse
|